A polymorphic DNA marker genetically linked to Huntington's disease.
paper
Cited
Public
Unavailable
- Authors
- Gusella, J F; Wexler, N S; Conneally, P M; Naylor, S L; Anderson, M A; Tanzi, R E; Watkins, P C; Ottina, K; Wallace, M R; Sakaguchi, A Y
- Year
- 1983
- Journal
- Nature
- PMID
- 6316146
- DOI
- 10.1038/306234a0
Family studies show that the Huntington's disease gene is linked to a polymorphic DNA marker that maps to human chromosome 4. The chromosomal localization of the Huntington's disease gene is the first step in using recombinant DNA technology to identify the primary genetic defect in this disorder.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Curing the brain: in search for new astrocyte-specific therapies. | Verkhratsky A et al. | — | 2026 | → |
| Patient Perspectives on Psychiatric Polygenic Risk Scores in Reproductive Decision-Making and Polygenic Embryo Screening. | Ginn LA et al. | — | 2026 | → |
| The clinical phenotype of carriers of intermediate alleles in the huntingtin gene: A scoping review. | van Hofslot A et al. | — | 2026 | → |
| What is the prevalence of sleep disturbances among people with Huntington disease and pre-manifest genetic expansion carriers? A systematic review and meta-analysis. | Sneddon NJ et al. | — | 2026 | → |
| A rare genetic variant confers resistance to neurodegeneration across multiple neurological disorders by augmenting selective autophagy. | Croce KR et al. | — | 2025 | → |
| Cerium-based nanoparticles for neurodegeneration: emerging redox therapeutics beyond pharmaceuticals. | Mishra K et al. | — | 2025 | → |
| Decoding the Alphabet Soup: A Practical Guide to Genetic Testing in Hyperkinetic Movement Disorders. | Del Gamba C et al. | — | 2025 | → |
| Huntingtin CAG repeat size variations below the Huntington's disease threshold: associations with depression, anxiety and basal ganglia structure. | Vater M et al. | — | 2025 | → |
| Inhibiting Cytosine-Adenine-Guanine (CAG) repeat expansions as a therapeutic strategy for Huntington's disease. | Winquist RJ et al. | — | 2025 | → |
| Lessons learned from 30 years of presymptomatic testing in Huntington Disease. | Pierron L et al. | — | 2025 | → |
| Locally adapting digital health technologies to address the global challenge of Parkinson's disease. | Lizárraga KJ et al. | — | 2025 | → |
| Rare diseases: ethical challenges in the era of digital health. | Siderius L et al. | — | 2025 | → |
| The role of mitochondrial dysfunction in Huntington's disease: Implications for therapeutic targeting. | Joshi DC et al. | — | 2025 | → |
| Unraveling mitochondrial dysfunction: comprehensive perspectives on its impact on neurodegenerative diseases. | Mohamed Yusoff AA et al. | — | 2025 | → |
| Update on Genetic Chorea. | Pérez-Pérez J et al. | — | 2025 | → |
| A review of neurogenetics in fetal and neonatal clinical medicine. | Ananth AL et al. | — | 2024 | → |
| Bilateral deep brain stimulation (DBS) of globus pallidus internus (GPi) for the treatment of benign hereditary chorea and other childhood onset choreas: a single-center experience. | Kurzbuch AR et al. | — | 2024 | → |
| Brain-Periphery Interactions in Huntington's Disease: Mediators and Lifestyle Interventions. | Burtscher J et al. | — | 2024 | → |
| Break-up and recovery of harmony between direct and indirect pathways in the basal ganglia: Huntington's disease and treatment. | Kim SY et al. | — | 2024 | → |
| Cognitive engagement may slow clinical progression and brain atrophy in Huntington's disease. | De Paepe AE et al. | — | 2024 | → |
| Deregulated Transcriptome as a Platform for Adrenal Huntington's Disease-Related Pathology. | Olechnowicz A et al. | — | 2024 | → |
| Dilated Cardiomyopathy: A Genetic Journey from Past to Future. | Newman NA et al. | — | 2024 | → |
| Discovery of novel genetic syndromes in Latin America: Opportunities and challenges. | Faundes V et al. | — | 2024 | → |
| Emerging antibody-based therapies for Huntington's disease: current status and perspectives for future development. | Jurcau A et al. | — | 2024 | → |
| Epidemiology of Huntington's Disease in Latin America: A Systematic Review and Meta-Analysis. | Medina Escobar A et al. | — | 2024 | → |
| Epigenetics in rare neurological diseases. | Roberts CT et al. | — | 2024 | → |
| From capture to detection: A critical review of passive sampling techniques for pathogen surveillance in water and wastewater. | Hayes EK et al. | — | 2024 | → |
| GPAD: a natural language processing-based application to extract the gene-disease association discovery information from OMIM. | Rahit KMTH et al. | — | 2024 | → |
| Human genetics of face recognition: discovery of MCTP2 mutations in humans with face blindness (congenital prosopagnosia). | Sun Y et al. | — | 2024 | → |
| Huntingtin CAG repeat size variations outside the Huntington’s disease complex: associations with depression and anxiety phenotypes and basal ganglia structure | Vater M et al. | — | 2024 | — |
| Microglia in Neurodegenerative Diseases. | Awogbindin I et al. | — | 2024 | → |
| Neuronal threshold functions: Determining symptom onset in neurological disorders. | Jordi L et al. | — | 2024 | → |
| Obsessive-compulsive and perseverative behaviors in Huntington's disease. | Zadegan SA et al. | — | 2024 | → |
| Oligodendrocytes in Huntington's Disease: A Review of Oligodendrocyte Pathology and Current Cell Reprogramming Approaches for Oligodendrocyte Modelling of Huntington's Disease. | Back AM et al. | — | 2024 | → |
| Protective Proteolysis in Huntington's Disease: Unraveling the Role of Post-Translational Myristoylation of Huntingtin in Autophagy. | Alshehabi Y et al. | — | 2024 | → |
| RNAi-based drug design: considerations and future directions. | Tang Q et al. | — | 2024 | → |
| The Huntington's Disease Gene Discovery. | Franklin GL et al. | — | 2024 | → |
| Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders. | Brandebura AN et al. | — | 2023 | → |
| Astrocytes in human central nervous system diseases: a frontier for new therapies. | Verkhratsky A et al. | — | 2023 | → |
| Celebrating a Century of Research in Behavioral Genetics. | Plomin R | — | 2023 | → |
| Editorial: New insight into Huntington's disease: From neuropathology to possible therapeutic targets. | Estrada-Sánchez AM et al. | — | 2023 | → |
| Genetic risk for Huntington Disease and reproductive decision-making: A systematic review. | Fahy N et al. | — | 2023 | → |
| Genetic substrates of bipolar disorder risk in Latino families. | Escamilla M et al. | — | 2023 | → |
| Leveraging Single-Cell Populations to Uncover the Genetic Basis of Complex Traits. | Minow MAA et al. | — | 2023 | → |
| Migratory Response of Cells in Neurogenic Niches to Neuronal Death: The Onset of Harmonic Repair? | Geribaldi-Doldán N et al. | — | 2023 | → |
| mtDNA Maintenance and Alterations in the Pathogenesis of Neurodegenerative Diseases. | Shang D et al. | — | 2023 | → |
| NAADP-Evoked Ca<sup>2+</sup> Signaling Leads to Mutant Huntingtin Aggregation and Autophagy Impairment in Murine Astrocytes. | Pereira CAS et al. | — | 2023 | → |
| Peripheral Biomarkers in Manifest and Premanifest Huntington's Disease. | Morena E et al. | — | 2023 | → |
| Recent approaches on Huntington's disease (Review). | Palaiogeorgou AM et al. | — | 2023 | → |
| Sleep Disorders and Circadian Disruption in Huntington's Disease. | Saade-Lemus S et al. | — | 2023 | → |
| Subtyping monogenic disorders: Huntington disease. | Sturchio A et al. | — | 2023 | → |
| Survival in Huntington's disease and other young-onset dementias. | Loi SM et al. | — | 2023 | → |
| Thalamic Foxp2 regulates output connectivity and sensory-motor impairments in a model of Huntington's Disease. | Rodríguez-Urgellés E et al. | — | 2023 | → |
| Theoretical design for covering Engeletin with functionalized nanostructure-lipid carriers as neuroprotective agents against Huntington's disease via the nasal-brain route. | Smriti et al. | — | 2023 | → |
| A biological classification of Huntington's disease: the Integrated Staging System. | Tabrizi SJ et al. | — | 2022 | → |
| Advances in Modeling Polyglutamine Diseases Using Genome Editing Tools. | Karwacka M et al. | — | 2022 | → |
| An MDS Evidence-Based Review on Treatments for Huntington's Disease. | Ferreira JJ et al. | — | 2022 | → |
| Brain Alterations in Aged OVT73 Sheep Model of Huntington's Disease: An MRI Based Approach. | Taghian T et al. | — | 2022 | → |
| Characterizing the Impact of Primer-Template Mismatches on Recombinase Polymerase Amplification. | Higgins M et al. | — | 2022 | → |
| Circadian rhythms in neurodegenerative disorders. | Nassan M et al. | — | 2022 | → |
| Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort. | Petracca M et al. | — | 2022 | → |
| Current and Possible Future Therapeutic Options for Huntington's Disease. | Ferguson MW et al. | — | 2022 | → |
| Epigenetics and the International Classification of Functioning, Disability and Health Model: Bridging Nature, Nurture, and Patient-Centered Population Health. | Shields RK et al. | — | 2022 | → |
| Hunting for the cause: Evidence for prion-like mechanisms in Huntington's disease. | Donnelly KM et al. | — | 2022 | → |
| Huntingtin and Other Neurodegeneration-Associated Proteins in the Development of Intracellular Pathologies: Potential Target Search for Therapeutic Intervention. | Churkina Taran AS et al. | — | 2022 | → |
| Huntington's Disease: A Clinical Review. | Andhale R et al. | — | 2022 | → |
| Huntington's Disease Gene Hunters: An Expanding Tale. | Rosser AE et al. | — | 2022 | → |
| Integration of Protein Structure and Population-Scale DNA Sequence Data for Disease Gene Discovery and Variant Interpretation. | Li B et al. | — | 2022 | → |
| Leveraging the Genetic Diversity of Human Stem Cells in Therapeutic Approaches. | Tegtmeyer M et al. | — | 2022 | → |
| Medical care of rare and undiagnosed diseases: Prospects and challenges. | Shan Z et al. | — | 2022 | → |
| Molecular Pathophysiological Mechanisms in Huntington's Disease. | Jurcau A | — | 2022 | → |
| Mushroom Natural Products in Neurodegenerative Disease Drug Discovery. | Abitbol A et al. | — | 2022 | → |
| Pathogenesis of Huntington's Disease: An Emphasis on Molecular Pathways and Prevention by Natural Remedies. | Irfan Z et al. | — | 2022 | → |
| Postnatal Foxp2 regulates early psychiatric-like phenotypes and associated molecular alterations in the R6/1 transgenic mouse model of Huntington's disease. | Rodríguez-Urgellés E et al. | — | 2022 | → |
| Psychosocial Impact of Huntington's Disease and Incentives to Improve Care for Affected Families in the Underserved Region of the Slovak Republic. | Hubčíková K et al. | — | 2022 | → |
| Recent developments in the management of Huntington's disease. | Devadiga SJ et al. | — | 2022 | → |
| Role of genetic testing in hepatic, pancreatic, and biliary cancers. | Hewitt DB et al. | — | 2022 | → |
| The beginnings of the debate between the Mendelians and the Biometricians in psychiatric genetics: David Heron, Karl Pearson, Abraham Rosanoff, and Charles Davenport 1913-1914. | Kendler KS | — | 2022 | → |
| The Debate Between Two of the Founders of American Psychiatric Genetics, Aaron Rosanoff and Abraham Myerson, on Mendelian Models for Psychiatric Illness: 1911-1917. | Kendler KS | — | 2022 | → |
| The extra-cerebellar effects of spinocerebellar ataxia type 1 (SCA1): looking beyond the cerebellum. | Olmos V et al. | — | 2022 | → |
| Comparative route of administration studies using therapeutic siRNAs show widespread gene modulation in Dorset sheep. | Ferguson CM et al. | — | 2021 | → |
| Detecting and targeting neurodegenerative disorders using electrospun nanofibrous matrices: current status and applications. | Siafaka PI et al. | — | 2021 | → |
| Dissecting polygenic signals from genome-wide association studies on human behaviour. | Abdellaoui A et al. | — | 2021 | → |
| DNA polymerase θ promotes CAG•CTG repeat expansions in Huntington's disease via insertion sequences of its catalytic domain. | Chan KY et al. | — | 2021 | → |
| Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways. | Cano A et al. | — | 2021 | → |
| ER Stress-Sensor Proteins and ER-Mitochondrial Crosstalk-Signaling Beyond (ER) Stress Response. | Kumar V et al. | — | 2021 | → |
| Gene Hunting Approaches through the Combination of Linkage Analysis with Whole-Exome Sequencing in Mendelian Diseases: From Darwin to the Present Day. | Susgun S et al. | — | 2021 | → |
| Genetic Disease and Therapy. | Roth TL et al. | — | 2021 | → |
| Genetic testing in dementia - utility and clinical strategies. | Koriath CAM et al. | — | 2021 | → |
| Genetic variations in medical research in the past, at present and in the future. | Kamatani Y et al. | — | 2021 | → |
| History of the methodology of disease gene identification. | Antonarakis SE | — | 2021 | → |
| Hotspots of Human Mutation. | Nesta AV et al. | — | 2021 | → |
| Huntington's disease: lessons from prion disorders. | Alpaugh M et al. | — | 2021 | → |
| Huntington's disease: nearly four decades of human molecular genetics. | Gusella JF et al. | — | 2021 | → |
| Huntington's Disease Pathogenesis: Two Sequential Components. | Hong EP et al. | — | 2021 | → |
| Investigating Crosstalk Among PTMs Provides Novel Insight Into the Structural Basis Underlying the Differential Effects of Nt17 PTMs on Mutant Httex1 Aggregation. | Chiki A et al. | — | 2021 | → |
| Mitochondrial Abnormalities and Synaptic Damage in Huntington's Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics. | Sawant N et al. | — | 2021 | → |
| Obelisc: an identical-by-descent mapping tool based on SNP streak. | Sonehara K et al. | — | 2021 | → |
| PedMiner: a tool for linkage analysis-based identification of disease-associated variants using family based whole-exome sequencing data. | Zhou J et al. | — | 2021 | → |
| Site-Specific Phosphorylation of Huntingtin Exon 1 Recombinant Proteins Enabled by the Discovery of Novel Kinases. | Chiki A et al. | — | 2021 | → |
| A family-based genome-wide association study of recurrent aphthous stomatitis. | Bankvall M et al. | — | 2020 | → |
| A novel specific PERK activator reduces toxicity and extends survival in Huntington's disease models. | Ganz J et al. | — | 2020 | → |
| Association Between Toll-Like Receptor 4 (TLR4) and Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Genetic Variants and Clinical Progression of Huntington's Disease. | Vuono R et al. | — | 2020 | → |
| Confidential genetic testing and electronic health records: A survey of current practices among Huntington disease testing centers. | Eno CC et al. | — | 2020 | → |
| Cortical Network Dynamics Is Altered in Mouse Models of Huntington's Disease. | Donzis EJ et al. | — | 2020 | → |
| Diphenyl diselenide protects a Caenorhabditis elegans model for Huntington's disease by activation of the antioxidant pathway and a decrease in protein aggregation. | Bicca Obetine Baptista F et al. | — | 2020 | → |
| Distribution of the <i>HTT</i> Gene A1 and A2 Haplotypes Worldwide: A Systematic Review. | Apolinário TA et al. | — | 2020 | → |
| Erucic acid, a nutritional PPARδ-ligand may influence Huntington's disease pathogenesis. | Altinoz MA et al. | — | 2020 | → |
| Founder Effects of Spinocerebellar Ataxias in the American Continents and the Caribbean. | Rodríguez-Labrada R et al. | — | 2020 | → |
| From beta amyloid to altered proteostasis in Alzheimer's disease. | Bruni AC et al. | — | 2020 | → |
| Genetic testing for neurodegenerative diseases: Ethical and health communication challenges. | Roberts JS et al. | — | 2020 | → |
| Huntington's Disease-An Outlook on the Interplay of the HTT Protein, Microtubules and Actin Cytoskeletal Components. | Taran AS et al. | — | 2020 | → |
| Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease-affected families. | Apolinário TA et al. | — | 2020 | → |
| Massively Parallel Sequencing for Rare Genetic Disorders: Potential and Pitfalls. | McInerney-Leo AM et al. | — | 2020 | → |
| New developments in Huntington's disease and other triplet repeat diseases: DNA repair turns to the dark side. | Lahue RS | — | 2020 | → |
| Patient-reported impact of symptoms in Huntington disease: PRISM-HD. | Glidden AM et al. | — | 2020 | → |
| Small molecule targeting of RNA structures in neurological disorders. | Angelbello AJ et al. | — | 2020 | → |
| The contribution of glial cells to Huntington's disease pathogenesis. | Wilton DK et al. | — | 2020 | → |
| The Impact of CRISPR-Cas9 on Age-related Disorders: From Pathology to Therapy. | Caobi A et al. | — | 2020 | → |
| 2018 William Allan Award: Discovering the Genes for Common Disease: From Families to Populations. | Lander ES | — | 2019 | → |
| An active cognitive lifestyle as a potential neuroprotective factor in Huntington's disease. | Garcia-Gorro C et al. | — | 2019 | → |
| Autophagic and endo-lysosomal dysfunction in neurodegenerative disease. | Malik BR et al. | — | 2019 | → |
| Brain Microbiota in Huntington's Disease Patients. | Alonso R et al. | — | 2019 | → |
| Closing the 'phenotype gap' in precision medicine: improving what we measure to understand complex disease mechanisms. | MacRae CA | — | 2019 | → |
| Complete but not partial inhibition of glutamate transporters exacerbates cortical excitability in the R6/2 mouse model of Huntington's disease. | Estrada-Sánchez AM et al. | — | 2019 | → |
| Demonstration of prion-like properties of mutant huntingtin fibrils in both in vitro and in vivo paradigms. | Masnata M et al. | — | 2019 | → |
| EGF Treatment Improves Motor Behavior and Cortical GABAergic Function in the R6/2 Mouse Model of Huntington's Disease. | Marottoli FM et al. | — | 2019 | → |
| From Many to One to Many-the Search for Causes of Psychiatric Illness. | Kendler KS | — | 2019 | → |
| Huntington disease: A quarter century of progress since the gene discovery. | Testa CM et al. | — | 2019 | → |
| Inorganic polyphosphate, a multifunctional polyanionic protein scaffold. | Xie L et al. | — | 2019 | → |
| Lack of mutant huntingtin in cortical efferents improves behavioral inflexibility and corticostriatal dynamics in Huntington's disease mice. | Estrada-Sánchez AM et al. | — | 2019 | → |
| Mutant Huntingtin Affects Diabetes and Alzheimer's Markers in Human and Cell Models of Huntington's Disease. | Chaves G et al. | — | 2019 | → |
| Oligonucleotide Treatment for Huntington's Disease. | Fischbeck KH et al. | — | 2019 | → |
| Role of Phosphorylated Tau and Glucose Synthase Kinase 3 Beta in Huntington's Disease Progression. | Sawant N et al. | — | 2019 | → |
| Speech in prodromal and symptomatic Huntington's disease as a model of measuring onset and progression in dominantly inherited neurodegenerative diseases. | Chan JCS et al. | — | 2019 | → |
| The Era of the Genome and Dental Medicine. | Divaris K | — | 2019 | → |
| The risks of converting post-hoc findings into primary outcomes in subsequent trials. | Rodrigues FB et al. | — | 2019 | → |
| The Role of Microglia and Astrocytes in Huntington's Disease. | Palpagama TH et al. | — | 2019 | → |
| The Scientific Case for Brain Simulations. | Einevoll GT et al. | — | 2019 | → |
| Advances in the discovery of genetic risk factors for complex forms of neurodegenerative disorders: contemporary approaches, success, challenges and prospects. | Kumar S et al. | — | 2018 | → |
| A Novel Therapy for Huntington's Disease. | La Spada AR | — | 2018 | → |
| A systematic linguistic profile of spontaneous narrative speech in pre-symptomatic and early stage Huntington's disease. | Hinzen W et al. | — | 2018 | → |
| Biofluid Biomarkers in Huntington's Disease. | Rodrigues FB et al. | — | 2018 | → |
| Clinical Features of Huntington's Disease. | Ghosh R et al. | — | 2018 | → |
| Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. | Erkkinen MG et al. | — | 2018 | → |
| Dose-Dependent Lowering of Mutant Huntingtin Using Antisense Oligonucleotides in Huntington Disease Patients. | van Roon-Mom WMC et al. | — | 2018 | → |
| Huntington disease. | Ghosh R et al. | — | 2018 | → |
| Huntington's disease-like disorders in Latin America and the Caribbean. | Walker RH et al. | — | 2018 | → |
| Huntington's disease: Neuropsychiatric manifestations of Huntington's disease. | Goh AM et al. | — | 2018 | → |
| Mitochondrial alterations accompanied by oxidative stress conditions in skin fibroblasts of Huntington's disease patients. | Jędrak P et al. | — | 2018 | → |
| Multiple sclerosis. | Cotsapas C et al. | — | 2018 | → |
| Murine Models of Huntington's Disease for Evaluating Therapeutics. | Kosior N et al. | — | 2018 | → |
| Pedigree Selection and Information Content. | Vardarajan BN et al. | — | 2018 | → |
| Piecing together the puzzle of Huntington's disease. | DeWeerdt S | — | 2018 | → |
| Population-specific genetic modification of Huntington's disease in Venezuela. | Chao MJ et al. | — | 2018 | → |
| Reactive Neuroblastosis in Huntington's Disease: A Putative Therapeutic Target for Striatal Regeneration in the Adult Brain. | Kandasamy M et al. | — | 2018 | → |
| RNA Related Pathology in Huntington's Disease. | Neueder A et al. | — | 2018 | → |
| Salivary biomarkers for the diagnosis and monitoring of neurological diseases. | Farah R et al. | — | 2018 | → |
| Salivary levels of total huntingtin are elevated in Huntington's disease patients. | Corey-Bloom J et al. | — | 2018 | → |
| Stem cell transplantation for Huntington's diseases. | Choi KA et al. | — | 2018 | → |
| Striatal neurons directly converted from Huntington's disease patient fibroblasts recapitulate age-associated disease phenotypes. | Victor MB et al. | — | 2018 | → |
| The Post-GWAS Era: From Association to Function. | Gallagher MD et al. | — | 2018 | → |
| Using Genome Sequence to Enable the Design of Medicines and Chemical Probes. | Angelbello AJ et al. | — | 2018 | → |
| What to Do with a Second Chance in Life? Long-Term Experiences of Non-carriers of Huntington's Disease. | Winnberg E et al. | — | 2018 | → |
| 2016 William Allan Award: Human Disease Research: Genetic Cycling and Re-cycling. | Gusella JF | — | 2017 | → |
| 2016 William Allan Award Introduction: James Gusella. | Nelson DL | — | 2017 | → |
| Brain Diffusivity and Structural Changes in the R6/2 Mouse Model of Huntington Disease. | Vorisek I et al. | — | 2017 | → |
| Discovery of Therapeutic Approaches for Polyglutamine Diseases: A Summary of Recent Efforts. | Esteves S et al. | — | 2017 | → |
| Endophenotype best practices. | Iacono WG et al. | — | 2017 | → |
| Epidemiological Study of Huntington's Disease in the Province of Ferrara, Italy. | Carrassi E et al. | — | 2017 | → |
| Epidemiology of Huntington disease. | Kay C et al. | — | 2017 | → |
| Factors related to genetic testing in adults at risk for Huntington disease: the prospective Huntington at-risk observational study (PHAROS). | Quaid KA et al. | — | 2017 | → |
| Gene polymorphisms associated with temperament. | Qiu X et al. | — | 2017 | → |
| Genetic counseling and testing for Huntington's disease: A historical review. | Nance MA | — | 2017 | → |
| Genetics of Huntington disease. | Nance MA | — | 2017 | → |
| Genetics of neurodegenerative diseases: an overview. | Pihlstrøm L et al. | — | 2017 | → |
| Huntington Disease: Genetics, Prevention, and Therapy Approaches. | Yapijakis C | — | 2017 | → |
| Identification and characterization of a missense mutation in the <i>O</i>-linked β-<i>N</i>-acetylglucosamine (<i>O</i>-GlcNAc) transferase gene that segregates with X-linked intellectual disability. | Vaidyanathan K et al. | — | 2017 | → |
| MicroRNAs in Neurodegenerative Diseases. | Quinlan S et al. | — | 2017 | → |
| Mitochondrial DNA levels in Huntington disease leukocytes and dermal fibroblasts. | Jędrak P et al. | — | 2017 | → |
| Neuropsychiatric Burden in Huntington's Disease. | Paoli RA et al. | — | 2017 | → |
| Pope Francis champions Huntington's disease. | Spinney L | — | 2017 | → |
| Sensory modulation intervention and behaviour support modification for the treatment of severe aggression in Huntington's disease. A single case experimental design. | Fisher CA et al. | — | 2017 | → |
| State of the Art and Beyond: Anterior Segment Diagnostics Genetic Diagnostics in Corneal Disease. | Davis KJ et al. | — | 2017 | → |
| Survival, Mortality, Causes and Places of Death in a European Huntington's Disease Prospective Cohort. | Rodrigues FB et al. | — | 2017 | → |
| The Complexity of Clinical Huntington's Disease: Developments in Molecular Genetics, Neuropathology and Neuroimaging Biomarkers. | Tippett LJ et al. | — | 2017 | → |
| The discovery of Alzheimer-causing mutations in the APP gene and the formulation of the "amyloid cascade hypothesis". | Hardy J | — | 2017 | → |
| The proportion of cancer-related entries in PubMed has increased considerably; is cancer truly "The Emperor of All Maladies"? | Reyes-Aldasoro CC | — | 2017 | → |
| The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders. | Smith DK et al. | — | 2017 | → |
| Unravelling the genetics of inherited retinal dystrophies: Past, present and future. | Broadgate S et al. | — | 2017 | → |
| An Integrated Data Driven Approach to Drug Repositioning Using Gene-Disease Associations. | Mullen J et al. | — | 2016 | → |
| Approaches to Validate and Manipulate RNA Targets with Small Molecules in Cells. | Childs-Disney JL et al. | — | 2016 | → |
| Cerebrospinal Fluid Inflammatory Biomarkers Reflect Clinical Severity in Huntington's Disease. | Rodrigues FB et al. | — | 2016 | → |
| Changes in mental state and behaviour in Huntington's disease. | Eddy CM et al. | — | 2016 | → |
| Corticostriatal Dysfunction in Huntington's Disease: The Basics. | Bunner KD et al. | — | 2016 | → |
| DNA methylation in Huntington's disease: Implications for transgenerational effects. | Thomas EA | — | 2016 | → |
| Exome and genome sequencing: a revolution for the discovery and diagnosis of monogenic disorders. | Stranneheim H et al. | — | 2016 | → |
| Genetically modified pig models for neurodegenerative disorders. | Holm IE et al. | — | 2016 | → |
| Genetic aspects of Huntington's disease in Latin America. A systematic review. | Castilhos RM et al. | — | 2016 | → |
| Genetics in Keratoconus: where are we? | Bykhovskaya Y et al. | — | 2016 | → |
| George Huntington: a legacy of inquiry, empathy and hope. | Wexler A et al. | — | 2016 | → |
| Human-to-mouse prion-like propagation of mutant huntingtin protein. | Jeon I et al. | — | 2016 | → |
| If genetic variation could talk: What genomic data may teach us about the importance of gene expression regulation in the genetics of autism. | Yeh E et al. | — | 2016 | → |
| In vivo proof-of-concept of removal of the huntingtin caspase cleavage motif-encoding exon 12 approach in the YAC128 mouse model of Huntington's disease. | Casaca-Carreira J et al. | — | 2016 | → |
| Quantitative Susceptibility Mapping Suggests Altered Brain Iron in Premanifest Huntington Disease. | van Bergen JM et al. | — | 2016 | → |
| The story of George Huntington and his disease. | Bhattacharyya KB | — | 2016 | → |
| Aberrant astrocytes impair vascular reactivity in Huntington disease. | Hsiao HY et al. | — | 2015 | → |
| Candidate gene-environment interaction research: reflections and recommendations. | Dick DM et al. | — | 2015 | → |
| Chorea: A Journey through History. | Vale TC et al. | — | 2015 | → |
| Clinical and genetic data of Huntington disease in Moroccan patients. | Bouhouche A et al. | — | 2015 | → |
| Clinical Aspects of Huntington's Disease. | Ghosh R et al. | — | 2015 | → |
| Correlation between relaxometry and diffusion tensor imaging in the globus pallidus of Huntington's disease patients. | Syka M et al. | — | 2015 | → |
| Genetic linkage analysis in the age of whole-genome sequencing. | Ott J et al. | — | 2015 | → |
| Guidelines for presymptomatic testing for Huntington's disease: past, present and future in France. | Clément S et al. | — | 2015 | → |
| Huntington disease. | Bates GP et al. | — | 2015 | → |
| Leveraging Epidemiologic and Clinical Collections for Genomic Studies of Complex Traits. | Crawford DC et al. | — | 2015 | → |
| Overview of genetic research in anorexia nervosa: The past, the present and the future. | Brandys MK et al. | — | 2015 | → |
| Perspectives on depression--past, present, future(a). | Barchas JD et al. | — | 2015 | → |
| Reduction in subventricular zone-derived olfactory bulb neurogenesis in a rat model of Huntington's disease is accompanied by striatal invasion of neuroblasts. | Kandasamy M et al. | — | 2015 | → |
| The genetic basis of hypertrophic cardiomyopathy in cats and humans. | Kittleson MD et al. | — | 2015 | → |
| The psychological impact of predictive genetic testing for Huntington's disease: a systematic review of the literature. | Crozier S et al. | — | 2015 | → |
| The role of tau in the pathological process and clinical expression of Huntington's disease. | Vuono R et al. | — | 2015 | → |
| Understanding inflammatory bowel disease via immunogenetics. | de Lange KM et al. | — | 2015 | → |
| Allele-specific suppression of mutant huntingtin using antisense oligonucleotides: providing a therapeutic option for all Huntington disease patients. | Skotte NH et al. | — | 2014 | → |
| C9ORF72: grabbing a tiger by the tail. | Mann D | — | 2014 | → |
| Combination of lycopene, quercetin and poloxamer 188 alleviates anxiety and depression in 3-nitropropionic acid-induced Huntington's disease in rats. | Jain D et al. | — | 2014 | → |
| Gene expression profile in fibroblasts of Huntington's disease patients and controls. | Marchina E et al. | — | 2014 | → |
| Genetically modified pigs to model human diseases. | Flisikowska T et al. | — | 2014 | → |
| Genetic modifiers of Huntington's disease. | Gusella JF et al. | — | 2014 | → |
| Genetics of gene expression in CNS. | Pandey AK et al. | — | 2014 | → |
| Genetic studies of Crohn's disease: past, present and future. | Liu JZ et al. | — | 2014 | → |
| HDL and cognition in neurodegenerative disorders. | Hottman DA et al. | — | 2014 | → |
| Highlights of the DNA cutters: a short history of the restriction enzymes. | Loenen WA et al. | — | 2014 | → |
| Identification of novel HSP90α/β isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating CNS disorders such as Huntington's disease. | Ernst JT et al. | — | 2014 | → |
| In vivo evaluation of candidate allele-specific mutant huntingtin gene silencing antisense oligonucleotides. | Southwell AL et al. | — | 2014 | → |
| Kazusa Marker DataBase: a database for genomics, genetics, and molecular breeding in plants. | Shirasawa K et al. | — | 2014 | → |
| Metabolism in HD: still a relevant mechanism? | Duan W et al. | — | 2014 | → |
| Metabotropic glutamate receptor 5 as a potential therapeutic target in Huntington's disease. | Ribeiro FM et al. | — | 2014 | → |
| Omental transplantation for neurodegenerative diseases. | Rafael H | — | 2014 | → |
| Prenatal testing for Huntington's disease in the Netherlands from 1998 to 2008. | van Rij MC et al. | — | 2014 | → |
| Stem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington's disease. | Choi KA et al. | — | 2014 | → |
| 'The clocks that time us'--circadian rhythms in neurodegenerative disorders. | Videnovic A et al. | — | 2014 | → |
| The junctophilin family of proteins: from bench to bedside. | Landstrom AP et al. | — | 2014 | → |
| Transgenic rat model of Huntington's disease: a histopathological study and correlations with neurodegenerative process in the brain of HD patients. | Mazurová Y et al. | — | 2014 | → |
| Translational paradigms in pharmacology and drug discovery. | Mullane K et al. | — | 2014 | → |
| Whole exome sequencing unravels disease-causing genes in consanguineous families in Qatar. | Fahiminiya S et al. | — | 2014 | → |
| A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases. | Paulsen JS et al. | — | 2013 | → |
| Autophagy as a neuroprotective mechanism against 3-nitropropionic acid-induced murine astrocyte cell death. | Pereira GJ et al. | — | 2013 | → |
| Chapter 15: disease gene prioritization. | Bromberg Y | — | 2013 | → |
| Constructing narratives of heroism and villainy: case study of Myriad's BRACAnalysis(®) compared to Genentech's Herceptin(®). | Baldwin AL et al. | — | 2013 | → |
| Dawn of ocular gene therapy: implications for molecular diagnosis in retinal disease. | Zaneveld J et al. | — | 2013 | → |
| Dosage transmission disequilibrium test (dTDT) for linkage and association detection. | Zhang Z et al. | — | 2013 | → |
| Genetically engineered pig models for human diseases. | Prather RS et al. | — | 2013 | → |
| Hunting human disease genes: lessons from the past, challenges for the future. | Brunham LR et al. | — | 2013 | → |
| Huntington's disease and cell therapies: past, present, and future. | Antoniades CA et al. | — | 2013 | → |
| Huntington's disease: the past, present, and future search for disease modifiers. | Clabough EB | — | 2013 | → |
| Integrative genomics in cardiovascular medicine. | Ware JS et al. | — | 2013 | → |
| Multiple sclerosis: individualized disease susceptibility and therapy response. | Pravica V et al. | — | 2013 | → |
| NMDA Receptor Activity in Neuropsychiatric Disorders. | Lakhan SE et al. | — | 2013 | → |
| Objective acoustic quantification of phonatory dysfunction in Huntington's disease. | Rusz J et al. | — | 2013 | → |
| Prefrontal executive function associated coupling relates to Huntington's disease stage. | Unschuld PG et al. | — | 2013 | → |
| Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records. | Evans SJ et al. | — | 2013 | → |
| Quality in genetic counselling for presymptomatic testing--clinical guidelines for practice across the range of genetic conditions. | Skirton H et al. | — | 2013 | → |
| Role of cerebral cortex in the neuropathology of Huntington's disease. | Estrada-Sánchez AM et al. | — | 2013 | → |
| Role of oxidative DNA damage in mitochondrial dysfunction and Huntington's disease pathogenesis. | Ayala-Peña S | — | 2013 | → |
| TACC3 is essential for EGF-mediated EMT in cervical cancer. | Ha GH et al. | — | 2013 | → |
| TACC3 promotes epithelial-mesenchymal transition (EMT) through the activation of PI3K/Akt and ERK signaling pathways. | Ha GH et al. | — | 2013 | → |
| The importance of rare DNA variation in neurologic disease: cautionary tale. | Haines JL | — | 2013 | → |
| Transforming acidic coiled-coil proteins (TACCs) in human cancer. | Ha GH et al. | — | 2013 | → |
| Triplet repeat primed PCR simplifies testing for Huntington disease. | Jama M et al. | — | 2013 | → |
| What counts as effective genetic counselling for presymptomatic testing in late-onset disorders? A study of the consultand's perspective. | Guimarães L et al. | — | 2013 | → |
| Age, CAG repeat length, and clinical progression in Huntington's disease. | Rosenblatt A et al. | — | 2012 | → |
| 'All the burden on all the carers': exploring quality of life with family caregivers of Huntington's disease patients. | Aubeeluck AV et al. | — | 2012 | → |
| Brain metabolite alterations and cognitive dysfunction in early Huntington's disease. | Unschuld PG et al. | — | 2012 | → |
| Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region. | Lee JM et al. | — | 2012 | → |
| Comparing linkage and association analyses in sheep points to a better way of doing GWAS. | Kemper KE et al. | — | 2012 | → |
| Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington's disease: interactions between neurons and astrocytes. | Estrada-Sánchez AM et al. | — | 2012 | → |
| Depressive symptoms in prodromal Huntington's Disease correlate with Stroop-interference related functional connectivity in the ventromedial prefrontal cortex. | Unschuld PG et al. | — | 2012 | → |
| Early alterations of brain cellular energy homeostasis in Huntington disease models. | Mochel F et al. | — | 2012 | → |
| [Elucidation of molecular pathomechanisms of Huntington's disease]. | Okazawa H | — | 2012 | → |
| Exome and whole-genome sequencing for gene discovery: the future is now! | Majewski J et al. | — | 2012 | → |
| Genetic polymorphism studies in periodontitis and Fcγ receptors. | Chai L et al. | — | 2012 | → |
| HDBuzz: empowering patients through accessible education. | Wild EJ et al. | — | 2012 | → |
| Huntington's disease: advocacy driving science. | Wexler NS | — | 2012 | → |
| Identification of rare variants from exome sequence in a large pedigree with autism. | Marchani EE et al. | — | 2012 | → |
| Lessons learned from the transgenic Huntington's disease rats. | Vlamings R et al. | — | 2012 | → |
| Native mutant huntingtin in human brain: evidence for prevalence of full-length monomer. | Sapp E et al. | — | 2012 | → |
| Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders. | Rabbani B et al. | — | 2012 | → |
| Personalizing rare disease research: how genomics is revolutionizing the diagnosis and treatment of rare disease. | Dolled-Filhart MP et al. | — | 2012 | → |
| Promoters are differentially sensitive to N-terminal mutant huntingtin-mediated transcriptional repression. | Hogel M et al. | — | 2012 | → |
| R6/2 Huntington's disease mice develop early and progressive abnormal brain metabolism and seizures. | Cepeda-Prado E et al. | — | 2012 | → |
| The genetics of multiple sclerosis: an up-to-date review. | Gourraud PA et al. | — | 2012 | → |
| The Prevalence of Juvenile Huntington's Disease: A Review of the Literature and Meta-Analysis. | Quarrell O et al. | — | 2012 | → |
| Using genomic data to make indirect (and unauthorized) estimates of disease risk. | Nyholt DR | — | 2012 | → |
| Witchcraft and Huntington's disease: a salutary history of societal and medical stigmatisation. | Loi S et al. | — | 2012 | → |
| A computational approach to candidate gene prioritization for X-linked mental retardation using annotation-based binary filtering and motif-based linear discriminatory analysis. | Lombard Z et al. | — | 2011 | → |
| Altered dopamine and serotonin metabolism in motorically asymptomatic R6/2 mice. | Mochel F et al. | — | 2011 | → |
| Américo Negrette and Huntington's disease. | Moscovich M et al. | — | 2011 | → |
| A methodology based on molecular interactions and pathways to find candidate genes associated to diseases: its application to schizophrenia and Alzheimer's disease. | Ochagavía ME et al. | — | 2011 | → |
| Body composition in premanifest Huntington's disease reveals lower bone density compared to controls. | Goodman AO et al. | — | 2011 | → |
| Characterizing amyloid-beta protein misfolding from molecular dynamics simulations with explicit water. | Lee C et al. | — | 2011 | → |
| Deficiency of huntingtin has pleiotropic effects in the social amoeba Dictyostelium discoideum. | Myre MA et al. | — | 2011 | → |
| Do genome-wide association scans have potential for translation? | Lopes MC et al. | — | 2011 | → |
| Electroconvulsive shock ameliorates disease processes and extends survival in huntingtin mutant mice. | Mughal MR et al. | — | 2011 | → |
| Energy deficit in Huntington disease: why it matters. | Mochel F et al. | — | 2011 | → |
| Factors contributing to institutionalization in patients with Huntington's disease. | Rosenblatt A et al. | — | 2011 | → |
| Family-based designs for genome-wide association studies. | Ott J et al. | — | 2011 | → |
| Genetics and neuropathology of Huntington's disease. | Reiner A et al. | — | 2011 | → |
| Genome-wide genetic marker discovery and genotyping using next-generation sequencing. | Davey JW et al. | — | 2011 | → |
| Genomic medicine and neurological disease. | Boone PM et al. | — | 2011 | → |
| Huntington disease: Implications for practice. | Cummins A et al. | — | 2011 | → |
| Huntington's disease research and practice: reflections on the journey made and lessons learned. | Goh AM et al. | — | 2011 | → |
| Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history. | Seidman CE et al. | — | 2011 | → |
| Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions. | Dreyer JL | — | 2011 | → |
| Linkage analysis in the next-generation sequencing era. | Bailey-Wilson JE et al. | — | 2011 | → |
| Meet me halfway: when genomics meets structural bioinformatics. | Gong S et al. | — | 2011 | → |
| Molecular biology of Huntington's disease. | McFarland KN et al. | — | 2011 | → |
| More appreciation of life or regretting the test? Experiences of living as a mutation carrier of Huntington's disease. | Hagberg A et al. | — | 2011 | → |
| Nonprimary dystonias. | Dressler D | — | 2011 | → |
| Oxidative stress in neurodegeneration. | Shukla V et al. | — | 2011 | → |
| PET translates neurophysiology into images: A review to stimulate a network between neuroimaging and basic research. | Giovacchini G et al. | — | 2011 | → |
| Progress and promise of genome-wide association studies for human complex trait genetics. | Stranger BE et al. | — | 2011 | → |
| Strategies for regenerating striatal neurons in the adult brain by using endogenous neural stem cells. | Nakaguchi K et al. | — | 2011 | → |
| The ethics of disclosing genetic diagnosis for Alzheimer's disease: do we need a new paradigm? | Arribas-Ayllon M | — | 2011 | → |
| 'The missing genes: what happened to the heritability of psychiatric disorders?'. | Crow TJ | — | 2011 | → |
| The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease. | Klempíř J et al. | — | 2011 | → |
| Transgenic Animal Models of Huntington's Disease. | Yang SH et al. | — | 2011 | → |
| Transgenic animal models of neurodegeneration based on human genetic studies. | Harvey BK et al. | — | 2011 | → |
| Unlocking Mendelian disease using exome sequencing. | Gilissen C et al. | — | 2011 | → |
| William Allan Award Address: On the role and soul of a statistical geneticist. | Ott J | — | 2011 | → |
| A double blind evaluation of cognitive decline in a Norwegian cohort of asymptomatic carriers of Huntington's disease. | van Walsem MR et al. | — | 2010 | → |
| ASIP Outstanding Investigator Award Lecture. New approaches to the pathology and genetics of neurodegeneration. | Feany MB | — | 2010 | → |
| Cerebellar lipid differences between R6/1 transgenic mice and humans with Huntington's disease. | Denny CA et al. | — | 2010 | → |
| Chapter 24: the coming of molecular biology and its impact on clinical neurology. | Smith CU | — | 2010 | → |
| Chapter 33: the history of movement disorders. | Lanska DJ | — | 2010 | → |
| Chapter 49: clinical neurology in Latin America. | Allegri RF | — | 2010 | → |
| Genetics of complex disorders. | Kere J | — | 2010 | → |
| Huntington's disease: a clinical review. | Roos RA | — | 2010 | → |
| Huntington's disease and mitochondrial alterations: emphasis on experimental models. | Pérez-De la Cruz V et al. | — | 2010 | → |
| Latrepirdine, a potential novel treatment for Alzheimer's disease and Huntington's chorea. | Sabbagh MN et al. | — | 2010 | → |
| Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions. | Dreyer JL | — | 2010 | → |
| Mendelian disorders and multifactorial traits: the big divide or one for all? | Antonarakis SE et al. | — | 2010 | → |
| Mitochondrial matters in Huntington disease. | Sack GH | — | 2010 | → |
| Molecular mechanisms and potential therapeutical targets in Huntington's disease. | Zuccato C et al. | — | 2010 | → |
| Neurogenetics: advancing the "next-generation" of brain research. | Zoghbi HY et al. | — | 2010 | → |
| New Genetic Findings in Schizophrenia: Is there Still Room for the Dopamine Hypothesis of Schizophrenia? | Nieratschker V et al. | — | 2010 | → |
| Pharmacogenetics in heart failure: how it will shape the future. | Hamad E et al. | — | 2010 | → |
| Whole-genome linkage and association scan in primary, nonsyndromic vesicoureteric reflux. | Cordell HJ et al. | — | 2010 | → |
| Adult neurogenesis and its alteration under pathological conditions. | Kaneko N et al. | — | 2009 | → |
| Allelic association: linkage disequilibrium structure and gene mapping. | Collins A | — | 2009 | → |
| Calcium and cell death signaling in neurodegeneration and aging. | Smaili S et al. | — | 2009 | → |
| Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease. | Allen KL et al. | — | 2009 | → |
| Changing models of biomedical research. | Crowley WF et al. | — | 2009 | → |
| Common variants on chromosome 2 and risk of primary open-angle glaucoma in the Afro-Caribbean population of Barbados. | Jiao X et al. | — | 2009 | → |
| Comparison of automated candidate gene prediction systems using genes implicated in type 2 diabetes by genome-wide association studies. | Teber ET et al. | — | 2009 | → |
| DNA variations in human and medical genetics: 25 years of my experience. | Nakamura Y | — | 2009 | → |
| Four decades of neurodegenerative disease research: how far we have come! | Young AB | — | 2009 | → |
| Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments. | McKeon A et al. | — | 2009 | → |
| Genomewide association studies: history, rationale, and prospects for psychiatric disorders. | Psychiatric GWAS Consortium Coordinating Committee et al. | — | 2009 | → |
| Glutamate toxicity in the striatum of the R6/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters. | Estrada-Sánchez AM et al. | — | 2009 | → |
| Huntington disease (chorea) in the middle East. | Scrimgeour EM | — | 2009 | → |
| Mendelian-inherited heart disease: a gateway to understanding mechanisms in heart disease Update on work done at the University of Stellenbosch. | Brink PA et al. | — | 2009 | → |
| Mitochondrial structural and functional dynamics in Huntington's disease. | Reddy PH et al. | — | 2009 | → |
| Molecular cloning and characterization of the common marmoset huntingtin gene. | Hohjoh H et al. | — | 2009 | → |
| Movement disorders. | Harris MK et al. | — | 2009 | → |
| Polymorphism of HD and UCHL-1 genes in Huntington's disease. | Xu EH et al. | — | 2009 | → |
| Presymptomatic diagnosis in Huntington's disease: the Mexican experience. | Alonso ME et al. | — | 2009 | → |
| Repeat instability in the 27-39 CAG range of the HD gene in the Venezuelan kindreds: Counseling implications. | Brocklebank D et al. | — | 2009 | → |
| Single-step detection of mutant huntingtin in animal and human tissues: a bioassay for Huntington's disease. | Weiss A et al. | — | 2009 | → |
| Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models. | Menalled L et al. | — | 2009 | → |
| The predicted structure of the headpiece of the Huntingtin protein and its implications on Huntingtin aggregation. | Kelley NW et al. | — | 2009 | → |
| Therapeutic opportunities of small interfering RNA. | Goyal BR et al. | — | 2009 | → |
| [About Huntington's disease: role of families and health professionals in information transmission]. | Delliaux M et al. | — | 2008 | → |
| Analysis of CCG repeats in Huntingtin gene among HD patients and normal populations in Japan. | Morovvati S et al. | — | 2008 | → |
| Decade of the mind. | Spitzer M | — | 2008 | → |
| Engagement with genetic discrimination: concerns and experiences in the context of Huntington disease. | Bombard Y et al. | — | 2008 | → |
| Excitotoxic neuronal death and the pathogenesis of Huntington's disease. | Estrada Sánchez AM et al. | — | 2008 | → |
| Family study designs in the age of genome-wide association studies: experience from the Framingham Heart Study. | Cupples LA | — | 2008 | → |
| From linkage maps to quantitative trait loci: the history and science of the Utah genetic reference project. | Prescott SM et al. | — | 2008 | → |
| Genetic determinants of phenotypic diversity in humans. | Rahim NG et al. | — | 2008 | → |
| Genetic mapping in human disease. | Altshuler D et al. | — | 2008 | → |
| Genomewide linkage scan reveals novel loci modifying age of onset of Huntington's disease in the Venezuelan HD kindreds. | Gayán J et al. | — | 2008 | → |
| Huntington disease mutation in Venezuela: age of onset, haplotype analyses and geographic aggregation. | Paradisi I et al. | — | 2008 | → |
| Huntington's disease. Part 1: essential background and management. | Aubeeluck A et al. | — | 2008 | → |
| Huntington's disease. Part 2: treatment and management issues in juvenile HD. | Aubeeluck A et al. | — | 2008 | → |
| Living at risk: concealing risk and preserving hope in Huntington disease. | Quaid KA et al. | — | 2008 | → |
| [Molecular and genetic analysis of spinocerebellar ataxia type 10 (SCA10)]. | Matsuura T | — | 2008 | → |
| Molecular physiology of weight regulation in mice and humans. | Leibel RL | — | 2008 | → |
| Normal and pathological aging of attention in presymptomatic Huntington's, Huntington's and Alzheimer's Disease, and nondemented elderly subjects. | Peretti CS et al. | — | 2008 | → |
| Obsessive-Compulsive Disorder Symptoms in Huntington's Disease: A Case Report. | Molano-Eslava JC et al. | — | 2008 | → |
| The basal ganglia: an overview of circuits and function. | Utter AA et al. | — | 2008 | → |
| The current clinical management of Huntington's disease. | Phillips W et al. | — | 2008 | → |
| The metabolic profile of early Huntington's disease--a combined human and transgenic mouse study. | Goodman AO et al. | — | 2008 | → |
| The road to genome-wide association studies. | Kruglyak L | — | 2008 | → |
| Advocacy groups as research organizations: the PXE International example. | Terry SF et al. | — | 2007 | → |
| [Animal models of neurodegenerative diseases]. | Langui D et al. | — | 2007 | → |
| Development of genomic reference materials for Huntington disease genetic testing. | Kalman L et al. | — | 2007 | → |
| Effects of an intensive rehabilitation programme on patients with Huntington's disease: a pilot study. | Zinzi P et al. | — | 2007 | → |
| Genetic criteria for Huntington's disease pathogenesis. | Gusella JF et al. | — | 2007 | → |
| Genetics in multiple sclerosis: past and future perspectives. | Harbo HF et al. | — | 2007 | → |
| Higher levels of extroverted hostility detected in gene carriers at risk for Huntington's disease. | Vassos E et al. | — | 2007 | → |
| Mitochondria and neurodegeneration. | Petrozzi L et al. | — | 2007 | → |
| MR relaxometry in Huntington's disease: correlation between imaging, genetic and clinical parameters. | Vymazal J et al. | — | 2007 | → |
| PCR approach for detection of Fragile X syndrome and Huntington disease based on modified DNA: limits and utility. | Rosales-Reynoso MA et al. | — | 2007 | → |
| Progenitor cells and adult neurogenesis in neurodegenerative diseases and injuries of the basal ganglia. | Curtis MA et al. | — | 2007 | → |
| Psychopathology in verified Huntington's disease gene carriers. | van Duijn E et al. | — | 2007 | → |
| Risk reduction and health promotion behaviors following genetic testing for adult-onset disorders. | Beery TA et al. | — | 2007 | → |
| The effect of neurodegenerative diseases on the subventricular zone. | Curtis MA et al. | — | 2007 | → |
| The Huntington's disease quality of life battery for carers: reliability and validity. | Aubeeluck A et al. | — | 2007 | → |
| To know or not to know: a review of behaviour and suicidal ideation in preclinical Huntington's disease. | Robins Wahlin TB | — | 2007 | → |
| 2005 William Allan Award address. No longer just looking under the lamppost. | Collins FS | — | 2006 | → |
| A hundred years of Alzheimer's disease research. | Hardy J | — | 2006 | → |
| Assessing genetic effects in survival data by correlating martingale residuals with an application to age at onset of Huntington disease. | Wintrebert CM et al. | — | 2006 | → |
| Depression and suicidal ideation after predictive testing for Huntington's disease: a two-year follow-up study. | Larsson MU et al. | — | 2006 | → |
| Fifteen years of experience in predictive testing for Huntington disease at a single testing center in Victoria, Australia. | Trembath MK et al. | — | 2006 | → |
| Genes and the environment in neurodegeneration. | Coppedè F et al. | — | 2006 | → |
| Genetic counseling for the public? | Kunstmann E et al. | — | 2006 | → |
| [Genetics of prevalent neurodegenerative disorders]. | Lladó A et al. | — | 2006 | → |
| Geriatric chorea. | Lorincz MT | — | 2006 | → |
| Movement disorders in Latin America. | Troiano AR et al. | — | 2006 | → |
| Neurogenesis in diseases of the central nervous system. | Phillips W et al. | — | 2006 | → |
| Present and future approaches to Parkinson disease: from molecular insights to new therapeutic avenues. | Fariello RG et al. | — | 2006 | → |
| Psychological aspects of pre-symptomatic testing for Machado-Joseph disease and familial amyloid polyneuropathy type I. | Rolim L et al. | — | 2006 | → |
| Role of genetic analyses in cardiology: part II: heritability estimation for gene searching in multifactorial diseases. | van Asselt KM et al. | — | 2006 | → |
| Striatal and extrastriatal atrophy in Huntington's disease and its relationship with length of the CAG repeat. | Ruocco HH et al. | — | 2006 | → |
| The association of CAG repeat length with clinical progression in Huntington disease. | Rosenblatt A et al. | — | 2006 | → |
| Therapeutic Strategies in Huntington's Disease. | Kanazawa I | — | 2006 | → |
| What makes a champion? Explaining variation in human athletic performance. | Brutsaert TD et al. | — | 2006 | → |
| When is a "positive" association truly a "positive" in psychiatric genetics? A commentary based on issues debated at the World Congress of Psychiatric Genetics, Boston, October 12-18, 2005. | DeLisi LE et al. | — | 2006 | → |
| 2004 Curt Stern Award Address. The SNP endgame: a multidisciplinary approach. | Risch N | — | 2005 | → |
| Caring for the carers: quality of life in Huntington's disease. | Aubeeluck A | — | 2005 | → |
| Case of maternally transmitted juvenile Huntington's disease with a very large trinucleotide repeat. | Papapetropoulos S et al. | — | 2005 | → |
| Genetics of developmental psychiatric disorders: pathways to discovery. | Joober R et al. | — | 2005 | → |
| Genetic studies to identify genes underlying menopausal age. | Kok HS et al. | — | 2005 | → |
| History of genetic disease: the molecular genetics of Huntington disease - a history. | Bates GP | — | 2005 | → |
| Imaging in cell-based therapy for neurodegenerative diseases. | Kirik D et al. | — | 2005 | → |
| Intact ability to learn internal models of arm dynamics in Huntington's disease but not cerebellar degeneration. | Smith MA et al. | — | 2005 | → |
| Nature, nurture and neurology: gene-environment interactions in neurodegenerative disease. FEBS Anniversary Prize Lecture delivered on 27 June 2004 at the 29th FEBS Congress in Warsaw. | Spires TL et al. | — | 2005 | → |
| Olfactory and auditory event-related potentials in Huntington's disease. | Wetter S et al. | — | 2005 | → |
| The biography of psychiatric genetics: from early achievements to historical burden, from an anxious society to critical geneticists. | Propping P | — | 2005 | → |
| The genetic epidemiology of neurodegenerative disease. | Bertram L et al. | — | 2005 | → |
| The patterns of natural variation in human genes. | Crawford DC et al. | — | 2005 | → |
| Adverse effects of predictive testing for Huntington disease underestimated: long-term effects 7-10 years after the test. | Timman R et al. | — | 2004 | → |
| Assessment of the nutrition status of patients with Huntington's disease. | Trejo A et al. | — | 2004 | → |
| Chorea and related disorders. | Bhidayasiri R et al. | — | 2004 | → |
| Clonal lymphocytes in persons without known chronic lymphocytic leukemia (CLL): implications of recent findings in family members of CLL patients. | Rawstron A et al. | — | 2004 | → |
| Detecting epistatic interactions contributing to quantitative traits. | Culverhouse R et al. | — | 2004 | → |
| Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16. | Djoussé L et al. | — | 2004 | → |
| Functional and motor response to low dose olanzapine in Huntington's disease: case report. | Laks J et al. | — | 2004 | → |
| Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington's disease. | Zucker B et al. | — | 2004 | → |
| Global genetic analysis. | Elahi E et al. | — | 2004 | → |
| Huntington disease: a case study of early onset presenting as depression. | Duesterhus P et al. | — | 2004 | → |
| Huntington's disease genetics. | Myers RH | — | 2004 | → |
| Impact on couple relationships of predictive testing for Huntington disease: a longitudinal study. | Richards F et al. | — | 2004 | → |
| Intelligence: genetics, genes, and genomics. | Plomin R et al. | — | 2004 | → |
| In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. | Fennema-Notestine C et al. | — | 2004 | → |
| Mitochondrial calcium, oxidative stress and apoptosis in a neurodegenerative disease model induced by 3-nitropropionic acid. | Rosenstock TR et al. | — | 2004 | → |
| Movement disorders. | Minagar A et al. | — | 2004 | → |
| Movement disorders in pregnancy. | Smith MS et al. | — | 2004 | → |
| Quantitative analysis of nucleic acids--the last few years of progress. | Ding C et al. | — | 2004 | → |
| The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration. | Leegwater-Kim J et al. | — | 2004 | → |
| The use of pedigree, sib-pair and association studies of common diseases for genetic mapping and epidemiology. | Freimer N et al. | — | 2004 | → |
| Turning the heterogeneous into homogeneous: studies on selectively isolated GABAergic interneuron subsets. | Berghuis P et al. | — | 2004 | → |
| Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. | Wexler NS et al. | — | 2004 | → |
| Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics. | Blum D et al. | — | 2003 | → |
| Cognitive and motor functioning in gene carriers for Huntington's disease: a baseline study. | Witjes-Ané MN et al. | — | 2003 | → |
| Diagnosis of Huntington disease. | Margolis RL et al. | — | 2003 | → |
| Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. | Botstein D et al. | — | 2003 | → |
| [DNA, 50 years of the double helix: from the concept of molecular hybridization to microarrays]. | Mornet E | — | 2003 | → |
| Genome-wide TDT analysis in a localized population with a high prevalence of multiple sclerosis indicates the importance of a region on chromosome 14q. | Giedraitis V et al. | — | 2003 | → |
| Hereditary causes of chorea in childhood. | Mathews KD | — | 2003 | → |
| Huntingtin in health and disease. | Young AB | — | 2003 | → |
| Huntington's disease: what we learned from the original essay. | Okun MS | — | 2003 | → |
| Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease. | Djoussé L et al. | — | 2003 | → |
| Mathematical multi-locus approaches to localizing complex human trait genes. | Hoh J et al. | — | 2003 | → |
| Modeling CNS neurodegeneration by overexpression of disease-causing proteins using viral vectors. | Kirik D et al. | — | 2003 | → |
| Neurogenetics: single gene disorders. | Pulst SM | — | 2003 | → |
| Nursing research linking genetics and health. | Williams JK | — | 2003 | → |
| Part 2: history of 20th century neurology: decade by decade. | Tyler K et al. | — | 2003 | → |
| Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000. | Creighton S et al. | — | 2003 | → |
| Psychopathology in the postgenomic era. | Plomin R et al. | — | 2003 | → |
| Testing the test--why pursue a better test for Huntington disease? | Timman R et al. | — | 2003 | → |
| The production and use of cells as therapeutic agents in neurodegenerative diseases. | Isacson O | — | 2003 | → |
| Whole-comparative genomic hybridization (W-CGH): 1. The quick overview of repetitive DNA sequences on a genome. | Pita M et al. | — | 2003 | → |
| A hereditary disorder in the family and the family life cycle: Huntington disease as a paradigm. | Brouwer-Dudokdewit AC et al. | — | 2002 | → |
| A perspective on epistasis: limits of models displaying no main effect. | Culverhouse R et al. | — | 2002 | → |
| Bridging genetics and genomics in neurology. | Cheung VG et al. | — | 2002 | → |
| Genetic and environmental factors in cancer and neurodegenerative diseases. | Migliore L et al. | — | 2002 | → |
| Genetic basis of anxiety-like behaviour: a critical review. | Clément Y et al. | — | 2002 | → |
| Homozygosity in Huntington's disease: new ethical dilemma caused by molecular diagnosis. | Alonso ME et al. | — | 2002 | → |
| Implications of multifactorial inheritance for identification of genetic mechanisms in major psychiatric disorders. | Nurnberger JI | — | 2002 | → |
| Non-disclosing preimplantation genetic diagnosis for Huntington disease. | Stern HJ et al. | — | 2002 | → |
| Predictability of age at onset in Huntington disease in the Dutch population. | Maat-Kievit A et al. | — | 2002 | → |
| Predictive testing in the context of pregnancy: experience in Huntington's disease and autosomal dominant cerebellar ataxia. | Lesca G et al. | — | 2002 | → |
| Search for a shared segment on chromosome 10q26 in patients with bipolar affective disorder or schizophrenia from the Faroe Islands. | Ewald H et al. | — | 2002 | → |
| Single-cell antisense RNA amplification and microarray analysis as a tool for studying neurological degeneration and restoration. | Kelz MB et al. | — | 2002 | → |
| Spinocerebellar degenerations: an update. | Perlman SL | — | 2002 | → |
| Weight loss in early stage of Huntington's disease. | Djoussé L et al. | — | 2002 | → |
| An animal model for the study of the genetic bases of behaviour in men: the multiple marker strains (MMS). | Clément Y et al. | — | 2001 | → |
| Caspases in Huntington's disease. | Sanchez Mejia RO et al. | — | 2001 | → |
| Clinical and counselling implications of preimplantation genetic diagnosis for Huntington's disease in the UK. | Lashwood A et al. | — | 2001 | → |
| Familial influence on age of onset among siblings with Huntington disease. | Rosenblatt A et al. | — | 2001 | → |
| Huntington's disease. | Davies S et al. | — | 2001 | → |
| Juvenile onset Huntington's disease--clinical and research perspectives. | Nance MA et al. | — | 2001 | → |
| Modeling Huntington's disease in cells, flies, and mice. | Sipione S et al. | — | 2001 | → |
| Neurobehavioral aspects of movement disorders. | Glosser G | — | 2001 | → |
| New problems in testing for Huntington's disease: the issue of intermediate and reduced penetrance alleles. | Maat-Kievit A et al. | — | 2001 | → |
| New therapeutic approaches for the treatment of Huntington's disease. | Mazurová Y | — | 2001 | → |
| Palliative care for people with late-stage Huntington's disease. | Moskowitz CB et al. | — | 2001 | → |
| Prenatal testing for Huntington's disease: experience within the UK 1994-1998. | Simpson SA et al. | — | 2001 | → |
| Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington's disease gene carriers. | Berrios GE et al. | — | 2001 | → |
| Psychological effect of genetic testing for Huntington's disease: an update of the literature. | Meiser B et al. | — | 2001 | → |
| Quantitative trait loci associated with reversal learning and latent inhibition in honeybees (Apis mellifera). | Chandra SB et al. | — | 2001 | → |
| Quantitative trait locus mapping: fishing strategy or replicable results? | Roubertoux PL et al. | — | 2001 | → |
| Restriction fragment length polymorphism analysis. | Jarcho J | — | 2001 | → |
| Rice genome analysis to understand the rice plant as an assembly of genetic codes. | Sasaki T | — | 2001 | → |
| The search for allelic variants that cause monogenic disorders or predispose to common, complex polygenic phenotypes. | Antonarakis SE | — | 2001 | → |
| A coalescent approach to study linkage disequilibrium between single-nucleotide polymorphisms. | Zöllner S et al. | — | 2000 | → |
| Bayesian fine-scale mapping of disease loci, by hidden Markov models. | Morris AP et al. | — | 2000 | → |
| Candidate genes showing no evidence for association or linkage with Alzheimer's disease using family-based methodologies. | Bertram L et al. | — | 2000 | → |
| Critical overview of current approaches to genetic mechanisms in schizophrenia research. | DeLisi LE | — | 2000 | → |
| DNA. | Plomin R et al. | — | 2000 | → |
| Drosophila models of human neurodegenerative disease. | Chan HY et al. | — | 2000 | → |
| Fetal tissue transplants in animal models of Huntington's disease: the effects on damaged neuronal circuitry and behavioral deficits. | Nakao N et al. | — | 2000 | → |
| Genetic mapping of complex traits: promises, problems, and prospects. | Guo SW et al. | — | 2000 | → |
| Genomic biology. | Brent R | — | 2000 | → |
| Genomics: journey to the center of biology. | Lander ES et al. | — | 2000 | → |
| Guilt by association. | Altshuler D et al. | — | 2000 | → |
| Impact of genome research on children and their families. | Williams JK | — | 2000 | → |
| Implications of genetic epidemiology for the prevention of substance use disorders. | Merikangas KR et al. | — | 2000 | → |
| Molecular diagnosis of Huntington disease in Brazilian patients. | Lima E Silva TC et al. | — | 2000 | → |
| Paradox of a better test for Huntington's disease. | Maat-Kievit A et al. | — | 2000 | → |
| Predictive testing for Huntington's disease: the calm after the storm. | Hayden MR | — | 2000 | → |
| Psychological impact of genetic testing for Huntington's disease: an update of the literature. | Meiser B et al. | — | 2000 | → |
| Redefinition: coping with normal results from predictive gene testing for neurodegenerative disorders. | Williams JK et al. | — | 2000 | → |
| Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. | Blum K et al. | — | 2000 | → |
| Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's Disease Prediction Consortium. | Harper PS et al. | — | 2000 | → |
| The emergence of modern neuroscience: some implications for neurology and psychiatry. | Cowan WM et al. | — | 2000 | → |
| The nosology of dementia. | Morris JC | — | 2000 | → |
| The psychological complexity of predictive testing for late onset neurogenetic diseases and hereditary cancers: implications for multidisciplinary counselling and for genetic education. | Evers-Kiebooms G et al. | — | 2000 | → |
| Benefits and pitfalls encountered in psychiatric genetic association studies. | Malhotra AK et al. | — | 1999 | → |
| Experience in prenatal testing for Huntington's disease in The Netherlands: procedures, results and guidelines (1987-1997). | Maat-Kievit A et al. | — | 1999 | → |
| Genome-wide search for linkage of bipolar affective disorders in a very large pedigree derived from a homogeneous population in quebec points to a locus of major effect on chromosome 12q23-q24. | Morissette J et al. | — | 1999 | → |
| Historical perspective of defining Charcot-Marie-Tooth type 1B. | Bird TD | — | 1999 | → |
| Historical Perspective of Defining Charcot-Marie-Tooth Type 1B. | Bird TD | — | 1999 | → |
| Huntington's disease: a clinical, genetic and molecular model for polyglutamine repeat disorders. | Harper PS | — | 1999 | → |
| Molecular basis of the neurodegenerative disorders. | Martin JB | — | 1999 | → |
| mRNAs encoding a von Ebner's-like protein and the Huntington disease protein are induced in rat male germ cells by Sertoli cells. | Syed V et al. | — | 1999 | → |
| Predictive and prenatal diagnosis of Huntington's disease: attitudes of Mexican neurologists, psychiatrists, and psychologists. | Alonso Vilatela ME et al. | — | 1999 | → |
| Predictive testing of 25 percent at-risk individuals for Huntington disease (1987-1997). | Maat-Kievit A et al. | — | 1999 | → |
| Psychological issues in genetic testing for breast cancer. | Carter CL et al. | — | 1999 | → |
| Recent advances in understanding the pathogenesis of Huntington's disease. | Reddy PH et al. | — | 1999 | → |
| Recent advances on the pathogenesis of Huntington's disease. | Petersén A et al. | — | 1999 | → |
| The concept of schizophrenia: pro et contra. | Jablensky A | — | 1999 | → |
| The evaluation of the 'stages of change' model for use in counselling client's undergoing predictive testing for Huntington's disease. | Houlihan GD | — | 1999 | → |
| The impact of genomics on mammalian neurobiology. | Hochgeschwender U et al. | — | 1999 | → |
| The missing link in linkage analysis: the well sibling revisited. | Fanos JH | — | 1999 | → |
| Allelic association under map error and recombinational heterogeneity: a tale of two sites. | Lonjou C et al. | — | 1998 | → |
| Child development, molecular genetics, and what to do with genes once they are found. | Plomin R et al. | — | 1998 | → |
| Course of distress experienced by persons at risk for an autosomal dominant inheritable disorder participating in a predictive testing program: an explorative study. Rotterdam/Leiden Genetics Workgroup. | Dudok deWit AC et al. | — | 1998 | → |
| Genetic classification of primary neurodegenerative disease. | Hardy J et al. | — | 1998 | → |
| Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington's disease. | Vuillaume I et al. | — | 1998 | → |
| Genetics of the hydrophilic surfactant proteins A and D. | Floros J et al. | — | 1998 | → |
| Huntington disease: clinical, genetic, and social aspects. | Nance MA | — | 1998 | → |
| Huntington's disease: review and anesthetic case management. | Cangemi CF et al. | — | 1998 | → |
| Linkage analysis and the tracking of susceptibility genes. | Stopps K et al. | — | 1998 | → |
| Molecular genetics of Huntington's disease. | MacDonald ME | — | 1998 | → |
| Molecular neurobiology and genetics: investigation of neural function and dysfunction. | Green T et al. | — | 1998 | → |
| Mutation in the gene encoding the fibroblast growth factor receptor-3 in Korean children with achondroplasia. | Yang SW et al. | — | 1998 | → |
| Oxidative stress and superoxide dismutase in development, aging and gene regulation. | Allen RG | — | 1998 | → |
| Predictive testing for Huntington's disease: a challenge for persons at risk and for professionals. | Evers-Kiebooms G et al. | — | 1998 | → |
| Predictive testing for Huntington's disease: ten years' experience in two Italian centres. | Mandich P et al. | — | 1998 | → |
| Prospectives for cell and gene therapy in Huntington's disease. | Bachoud-Lévi AC et al. | — | 1998 | → |
| Subtle involuntary movements are not reliable indicators of incipient Huntington's disease. | de Boo G et al. | — | 1998 | → |
| Treatment of the psychiatric manifestations of Huntington's disease: a review of the literature. | Leroi I et al. | — | 1998 | → |
| Unified Huntington's disease rating scale: a follow up. | Siesling S et al. | — | 1998 | → |
| Use of isolated inbred human populations for identification of disease genes. | Sheffield VC et al. | — | 1998 | → |
| 3-Nitropropionic acid animal model and Huntington's disease. | Borlongan CV et al. | — | 1997 | → |
| Analysis of the (CAG)n repeat causing Huntington's disease in a Mexican population. | Alonso ME et al. | — | 1997 | → |
| A review of Huntington's disease. | O'Shea B | — | 1997 | → |
| Challenges in Duchenne muscular dystrophy. | Davies KE | — | 1997 | → |
| Concordance of common movement disorders among familial cases. | Rajput AH et al. | — | 1997 | → |
| Detection of CAG repeats using silver staining in patients with Huntington disease in Hungary. | Tóth T et al. | — | 1997 | → |
| Diagnostic molecular genetics. | Sack GH | — | 1997 | → |
| Fine-scale genetic mapping based on linkage disequilibrium: theory and applications. | Xiong M et al. | — | 1997 | → |
| Genomic survey of bipolar illness in the NIMH genetics initiative pedigrees: a preliminary report. | — | — | 1997 | → |
| Grafts of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice: trophic and tropic effects in a rodent model of Huntington's disease. | Kordower JH et al. | — | 1997 | → |
| Human genetics: past, present, and future, with special reference to major trends in Japan. | Yanase T | — | 1997 | → |
| Huntington disease and the related disorder, dentatorubral-pallidoluysian atrophy (DRPLA). | Ross CA et al. | — | 1997 | → |
| Huntington's disease. | Haddad MS et al. | — | 1997 | → |
| Huntington's disease: psychiatric practice in molecular genetic prediction and diagnosis. | Scourfield J et al. | — | 1997 | → |
| Intelligence indices in people with a high/low risk for developing Huntington's disease. | de Boo GM et al. | — | 1997 | → |
| Long-term impact of Huntington disease linkage testing. | Taylor CA et al. | — | 1997 | → |
| Mouse models of human CAG repeat disorders. | Burright EN et al. | — | 1997 | → |
| Psychological opportunities and hazards in predictive genetic testing for cancer risk. | Codori AM | — | 1997 | → |
| Reactions to predictive testing in Huntington disease: case reports of coping with a new genetic status. | Wahlin TB et al. | — | 1997 | → |
| Risk reversals in predictive testing for Huntington disease. | Almqvist E et al. | — | 1997 | → |
| Strategies to identify genes for complex diseases. | Zhang H et al. | — | 1997 | → |
| The CAG/polyglutamine tract diseases: gene products and molecular pathogenesis. | Koshy BT et al. | — | 1997 | → |
| The genetic defect causing Huntington's disease: repeated in other contexts? | Gusella JF et al. | — | 1997 | → |
| The use of a genetic map of biallelic markers in linkage studies. | Kruglyak L | — | 1997 | → |
| A Dutch family with benign hereditary chorea of early onset: differentiation from Huntington's disease. | Hageman G et al. | — | 1996 | → |
| Cell-specific regulation of the stably expressed serotonin 5-HT1A receptor and altered ganglioside synthesis. | Singh JK et al. | — | 1996 | → |
| Huntington's disease. | Craufurd D | — | 1996 | → |
| Huntington's disease: confirmation of diagnosis and presymptomatic testing in Spanish families by genetic analysis. | Sánchez A et al. | — | 1996 | → |
| Huntington's disease predictive testing: the case for an assessment approach to requests from adolescents. | Binedell J et al. | — | 1996 | → |
| Intrastriatal implants of polymer encapsulated cells genetically modified to secrete human nerve growth factor: trophic effects upon cholinergic and noncholinergic striatal neurons. | Kordower JH et al. | — | 1996 | → |
| Issues in genetic testing for susceptibility to alcoholism: lessons from Alzheimer's disease and Huntington's disease. | Quaid KA et al. | — | 1996 | → |
| Late-onset Huntington's disease: a geriatric psychiatry perspective. | Shulman KI et al. | — | 1996 | → |
| Molecular genetics and craniofacial surgery. | Mulliken JB et al. | — | 1996 | → |
| Neurogenetic diseases: molecular diagnosis and therapeutic approaches. | Muller U et al. | — | 1996 | → |
| Neuropsychological stability over two years in asymptomatic carriers of the Huntington's disease mutation. | Campodonico JR et al. | — | 1996 | → |
| Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making. | Decruyenaere M et al. | — | 1996 | → |
| The molecular genetics of schizophrenia. | Murphy KC et al. | — | 1996 | → |
| The search for molecular defects in genetic disease. | Galjaard H | — | 1996 | → |
| Tourette's syndrome in the year 2000. | Robertson MM et al. | — | 1996 | → |
| Update on genetics of Huntington's disease: availability of direct and accurate predictive test. | Squitieri F et al. | — | 1996 | → |
| Visual processing disorders in patients with Huntington's disease and asymptomatic carriers. | Gómez-Tortosa E et al. | — | 1996 | → |
| A comparison of the Huntington's disease associated trinucleotide repeat between Chinese and white populations. | Soong BW et al. | — | 1995 | → |
| Are we all of one mind? Clinicians' and patients' opinions regarding the development of a service protocol for predictive testing for Huntington disease. Canadian Collaborative Study for Predictive Testing for Huntington Disease. | Copley TT et al. | — | 1995 | → |
| Chemical anatomy of primate basal ganglia. | Parent A et al. | — | 1995 | → |
| Cognitive performance in UK sample of presymptomatic people carrying the gene for Huntington's disease. | Blackmore L et al. | — | 1995 | → |
| DNA analysis of Huntington's disease in southern Chinese. | Chan V et al. | — | 1995 | → |
| Emotional and functional impact of DNA testing on patients with symptoms of Huntington's disease. | Jankovic J et al. | — | 1995 | → |
| Exclusion mapping of the benign hereditary chorea gene from the Huntington's disease locus: report of a family. | Yapijakis C et al. | — | 1995 | → |
| Gene therapy and pharmacological treatment of inherited neurological disorders. | Martin JB | — | 1995 | → |
| Genetic and molecular studies of macular dystrophies: recent developments. | Zhang K et al. | — | 1995 | → |
| Genetics and molecular biology of Huntington's disease. | Albin RL et al. | — | 1995 | → |
| Genetic susceptibility to nephropathy in insulin-dependent diabetes: from epidemiology to molecular genetics. | Doria A et al. | — | 1995 | → |
| Huntington disease: a case study describing the complexities and nuances of predictive testing of monozygotic twins. | Heimler A et al. | — | 1995 | → |
| Huntington's disease. | Gusella JF et al. | — | 1995 | → |
| Huntington's disease gene: regional and cellular expression in brain of normal and affected individuals. | Landwehrmeyer GB et al. | — | 1995 | → |
| Huntington's disease: recent advances in diagnosis and management. | Furtado S et al. | — | 1995 | → |
| Huntington's disease. Their loss is our gain? | Feero W et al. | — | 1995 | → |
| Neurogenetics: now and the future. | Martin JB | — | 1995 | → |
| Neuropsychological characteristics of Huntington's disease carriers: a double blind study. | Rosenberg NK et al. | — | 1995 | → |
| Normal and expanded Huntington's disease gene alleles produce distinguishable proteins due to translation across the CAG repeat. | Persichetti F et al. | — | 1995 | → |
| Origins and evolution of Huntington disease chromosomes. | Andrew SE et al. | — | 1995 | → |
| Presymptomatic testing for genetic diseases of later life. Pharmacoepidemiological considerations. | Rossiter BJ et al. | — | 1995 | → |
| Rare variants of chromosome 9 with extra G positive band within the qh region are not alike. | Conte RA et al. | — | 1995 | → |
| Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease. | Peschanski M et al. | — | 1995 | → |
| Somatic stability in chorionic villi samples and other Huntington fetal tissues. | Benitez J et al. | — | 1995 | → |
| The neuroscience perspective and the changing role of the psychiatrist : the challenge for psychiatric educators. | Coyle JT | — | 1995 | → |
| Unstable triplet repeat diseases. | Monckton DG et al. | — | 1995 | → |
| Variability in cognitive function among persons at high genetic risk of Huntington's disease. | Lundervold AJ et al. | — | 1995 | → |
| Vulnerability of medium spiny striatal neurons to glutamate: role of Na+/K+ ATPase. | Calabresi P et al. | — | 1995 | → |
| A comprehensive human linkage map with centimorgan density. Cooperative Human Linkage Center (CHLC). | Murray JC et al. | — | 1994 | → |
| A controlled psychiatric study of individuals at risk for Huntington's disease. | Shiwach RS et al. | — | 1994 | → |
| Acute and chronic behavioural sequelae resulting from intrastriatal injection of an NMDA agonist. | Black MD et al. | — | 1994 | → |
| Analysis of chromosome 22 loci in meningioma. Alterations in the leukemia inhibitory factor (LIF) locus. | Pergolizzi RG et al. | — | 1994 | → |
| Ethical issues in prenatal testing. | Burgess MM | — | 1994 | → |
| Excitotoxicity and neurological disorders: involvement of membrane phospholipids. | Farooqui AA et al. | — | 1994 | → |
| Genes with triplet repeats: a new class of mutations causing neurological diseases. | Plassart E et al. | — | 1994 | → |
| Gene therapy for neurological disorders. | Friedmann T | — | 1994 | → |
| Genetic anticipation. Expanding tandem repeats. | Carpenter NJ | — | 1994 | → |
| Genetic prediction of adult onset disease. | Simpson SA et al. | — | 1994 | → |
| Heritable trinucleotide repeats and neurological disorders. | Shastry BS | — | 1994 | → |
| High resolution localization of recombination hot spots using sperm typing. | Hubert R et al. | — | 1994 | → |
| Huntington's disease and repeating trinucleotides. | Gusella JF et al. | — | 1994 | → |
| Huntington's disease: pathogenesis, diagnosis and treatment. | Purdon SE et al. | — | 1994 | → |
| Huntington's disease: update and review of neuropsychiatric aspects. | Mendez MF | — | 1994 | → |
| Informed consent and Huntington disease: a model for communication. | Sharpe NF | — | 1994 | → |
| Molecular basis and diagnosis of neurogenetic disorders. | Müller U et al. | — | 1994 | → |
| Molecular biology of Huntington's disease. | Craufurd D | — | 1994 | → |
| Mouse Huntington's disease gene homolog (Hdh). | Barnes GT et al. | — | 1994 | → |
| Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. | Shiang R et al. | — | 1994 | → |
| Neurogenetics. Triumphs and challenges. | Greenstein P et al. | — | 1994 | → |
| Predictive testing for Huntington disease: a psychologist's view. | Kessler S | — | 1994 | → |
| Predictive testing for Huntington disease: social characteristics and knowledge of applicants, attitudes to the test procedure and decisions made after testing. | Holloway S et al. | — | 1994 | → |
| Proceed with care: direct predictive testing for Huntington disease. | Benjamin CM et al. | — | 1994 | → |
| Psychiatric genetic research at the National Institute of Mental Health. | Berg K et al. | — | 1994 | → |
| Psychological aspects of genetic counseling: a legal perspective. | Sharpe NF | — | 1994 | → |
| Psychological costs and benefits of predictive testing for Huntington's disease. | Codori AM et al. | — | 1994 | → |
| Self-selection in predictive testing for Huntington's disease. | Codori AM et al. | — | 1994 | → |
| Structure and expression of the Huntington's disease gene: evidence against simple inactivation due to an expanded CAG repeat. | Ambrose CM et al. | — | 1994 | → |
| Synteny conservation of the Huntington's disease gene and surrounding loci on mouse Chromosome 5. | Grosson CL et al. | — | 1994 | → |
| The human genome project: genetic and physical mapping. | Rosteck PR | — | 1994 | → |
| The human genome project Genetic and physical mapping. | Rosteck PR | — | 1994 | → |
| Trinucleotide repeat expansion in neurological disease. | La Spada AR et al. | — | 1994 | → |
| Trinucleotide repeat length and rate of progression of Huntington's disease. | Illarioshkin SN et al. | — | 1994 | → |
| Unstable trinucleotide repeats and the diagnosis of neurodegenerative disease. | Orr HT | — | 1994 | → |
| A clinico-genetic study of psychiatric disorder in Huntington's chorea. | Watt DC et al. | — | 1993 | → |
| A cosmid contig and high resolution restriction map of the 2 megabase region containing the Huntington's disease gene. | Baxendale S et al. | — | 1993 | → |
| A genetic linkage map of the chromosome 4 short arm. | Locke PA et al. | — | 1993 | → |
| A histometrical study on the globus pallidus in Huntington's disease. | Wakai M et al. | — | 1993 | → |
| A linkage study with DNA markers (D4S95, D4S115, and D4S111) in Japanese Huntington disease families. | Watanabe M et al. | — | 1993 | → |
| Allele frequencies and linkage disequilibrium of polymorphic DNA markers of the Huntington disease region in the German population. | Thies U et al. | — | 1993 | → |
| Alterations in neuropeptides in aging and disease. Pathophysiology and potential for clinical intervention. | Leake A et al. | — | 1993 | → |
| An expanding enigma. | Hoffman EP et al. | — | 1993 | → |
| Are linkage studies boring? | Bird TD | — | 1993 | → |
| A study of psychiatric morbidity in patients with Huntington's disease, their relatives, and controls. Admissions to psychiatric hospitals in Denmark from 1969 to 1991. | Jensen P et al. | — | 1993 | → |
| Attitudes of Dutch general practitioners towards presymptomatic DNA-testing for Huntington disease. | Thomassen R et al. | — | 1993 | → |
| Attitudes of neurologists, psychiatrists, and psychotherapists towards predictive testing for Huntington's disease in Germany. | Thies U et al. | — | 1993 | → |
| Behavioral effects of fetal neural transplants: relevance to Huntington's disease. | Sanberg PR et al. | — | 1993 | → |
| Chromosome 4 localization of a second gene for autosomal dominant polycystic kidney disease. | Peters DJ et al. | — | 1993 | → |
| Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease. | Kuwert T et al. | — | 1993 | → |
| De novo expansion of a (CAG)n repeat in sporadic Huntington's disease. | Myers RH et al. | — | 1993 | → |
| Diagnosis of Huntington disease: a model for the stages of psychological response based on experience of a predictive testing program. | Bloch M et al. | — | 1993 | → |
| Dynamic mutation in Dutch Huntington's disease patients: increased paternal repeat instability extending to within the normal size range. | De Rooij KE et al. | — | 1993 | → |
| Effect of laboratory or clerical error on presymptomatic risk calculations for Huntington disease: a simulation study. | King TM et al. | — | 1993 | → |
| Ensuring consumer safety. Predictive testing for Huntington disease: response to Dr. Seymour Kessler, "Reinventing the wheel". | Chapman MA | — | 1993 | → |
| Five year study of prenatal testing for Huntington's disease: demand, attitudes, and psychological assessment. | Adam S et al. | — | 1993 | → |
| Forgotten person in the Huntington disease family. | Kessler S | — | 1993 | → |
| FRAR course on laboratory approaches to aging. Genetic influences on aging in mammals and invertebrates. | Johnson TE | — | 1993 | → |
| Genetic epidemiologic studies of affective disorders in childhood and adolescence. | Merikangas KR | — | 1993 | → |
| Genetic fatalism and social policy: the implications of behavior genetics research. | Alper JS et al. | — | 1993 | → |
| Genetic linkage and schizophrenia: methods, recent findings and future directions. | Mowry BJ et al. | — | 1993 | → |
| Genotype relative risks: methods for design and analysis of candidate-gene association studies. | Schaid DJ et al. | — | 1993 | → |
| Human chromosome 21: genome mapping and exploration, circa 1993. | Antonarakis SE | — | 1993 | → |
| Hunting for Huntington's disease. | Gusella JF et al. | — | 1993 | → |
| Huntington's disease in Grampian region: correlation of the CAG repeat number and the age of onset of the disease. | Simpson SA et al. | — | 1993 | → |
| Huntington's disease: predictive testing and the molecular genetics laboratory. | Lazarou LP et al. | — | 1993 | → |
| Huntington's disease. The end of the beginning. | Little P | — | 1993 | → |
| Identification of an Alu retrotransposition event in close proximity to a strong candidate gene for Huntington's disease. | Goldberg YP et al. | — | 1993 | → |
| Linkage studies of psychiatric disorders. | Risch N et al. | — | 1993 | → |
| Methods for finding genes. A major rate-limiting step in positional cloning. | Parrish JE et al. | — | 1993 | → |
| Minireview: Molecular genetics in affective illness. | Mendlewicz J et al. | — | 1993 | → |
| Molecular analysis and clinical correlations of the Huntington's disease mutation. | MacMillan JC et al. | — | 1993 | → |
| Molecular genetics in neurology. | Martin JB | — | 1993 | → |
| Offering predictive testing for Huntington disease in a medical genetics clinic: Practical applications. | Bennett RL et al. | — | 1993 | → |
| On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program. | Tibben A et al. | — | 1993 | → |
| On planting alfalfa and growing orchids: the cloning of the gene causing Huntington disease. | Hayden MR | — | 1993 | → |
| Pericentric region of chromosome 9 is a possible candidate region for linkage study of schizophrenia. | Nanko S et al. | — | 1993 | → |
| Pilot study of computerised differentiation of Huntington's disease, schizophrenic, and Parkinson's disease patients using the contingent negative variation. | Jervis BW et al. | — | 1993 | → |
| Predictive testing for Huntington's disease: after the gene. The United Kingdom Huntington's Disease Prediction Consortium. | Simpson SA et al. | — | 1993 | → |
| Presymptomatic DNA testing for Huntington disease: identifying the need for psychological intervention. | Tibben A et al. | — | 1993 | → |
| Presymptomatic DNA-testing for Huntington disease: pretest attitudes and expectations of applicants and their partners in the Dutch program. | Tibben A et al. | — | 1993 | → |
| Presymptomatic testing for Huntington's disease: a world wide survey. The World Federation of Neurology Research Group on Huntington's Disease. | — | — | 1993 | → |
| Reluctance to undergo predictive testing: the case of Huntington disease. | Quaid KA et al. | — | 1993 | → |
| Reluctance to undergo predictive testing: the case of Huntington disease. | Quaid KA et al. | — | 1993 | → |
| Searching for human epilepsy genes: a progress report. | Leppert M et al. | — | 1993 | → |
| SPECT, CT and MRI in a Turkish family with Huntington's disease. | Bruyn RP et al. | — | 1993 | → |
| Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease. | Kuwert T et al. | — | 1993 | → |
| The distribution of GABAA-benzodiazepine receptors in the basal ganglia in Huntington's disease and in the quinolinic acid-lesioned rat. | Faull RL et al. | — | 1993 | → |
| The DNA laboratory and neurological practice. | Harding AE | — | 1993 | → |
| The gene for Huntington's disease. | Harding AE | — | 1993 | → |
| The human genome project. | Olson MV | — | 1993 | → |
| The normal Huntington disease (HD) allele, or a closely linked gene, influences age at onset of HD. | Farrer LA et al. | — | 1993 | → |
| The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. | Andrew SE et al. | — | 1993 | → |
| Trinucleotide repeat expansions in neurological disease. | Warren ST et al. | — | 1993 | → |
| Trinucleotide repeat length instability and age of onset in Huntington's disease. | Duyao M et al. | — | 1993 | → |
| Why there is no gene for alcoholism. | Devor EJ | — | 1993 | → |
| A high-resolution meiotic mapping panel for the pericentromeric region of chromosome 10. | Lichter JB et al. | — | 1992 | → |
| Anatomy and connectivity of intrastriatal striatal transplants. | Wictorin K | — | 1992 | → |
| An estimate of the number of genes in the Huntington disease gene region and the identification of 13 transcripts in the 4p16.3 segment. | Carlock L et al. | — | 1992 | → |
| A non-organic and non-enzymatic extraction method gives higher yields of genomic DNA from whole-blood samples than do nine other methods tested. | Lahiri DK et al. | — | 1992 | → |
| A recombination event that redefines the Huntington disease region. | Snell RG et al. | — | 1992 | → |
| Assay by polymerase chain reaction (PCR) of multi-allele polymorphisms in the Huntington's disease region of chromosome 4. | Allitto BA et al. | — | 1992 | → |
| Canadian experience with predictive testing for Huntington disease: lessons for genetic testing centers and policy makers. | Chapman MA | — | 1992 | → |
| Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 2-1992. Chorea and progressive dementia in an 88-year-old woman. | — | — | 1992 | → |
| Characterization of a yeast artificial chromosome contig spanning the Huntington's disease gene candidate region. | Bates GP et al. | — | 1992 | → |
| Chromosomal localization of three human D5 dopamine receptor genes. | Grandy DK et al. | — | 1992 | → |
| Chromosome mapping of the rod photoreceptor cGMP phosphodiesterase beta-subunit gene in mouse and human: tight linkage to the Huntington disease region (4p16.3). | Altherr MR et al. | — | 1992 | → |
| Cloning of the alpha-adducin gene from the Huntington's disease candidate region of chromosome 4 by exon amplification. | Taylor SA et al. | — | 1992 | → |
| Delineation of a 50 kilobase DNA segment containing the recombination site in a sporadic case of Huntington's disease. | Weber B et al. | — | 1992 | → |
| DNA-testing for Huntington's disease in The Netherlands: a retrospective study on psychosocial effects. | Tibben A et al. | — | 1992 | → |
| Doyne Lecture. Rhodopsin and autosomal dominant retinitis pigmentosa. | Dryja TP | — | 1992 | → |
| Epigene conversion: a proposal with implications for gene mapping in humans. | Sabl JF et al. | — | 1992 | → |
| Evidence of presymptomatic cognitive decline in Huntington's disease. | Diamond R et al. | — | 1992 | → |
| Expected behavior of conditional linkage disequilibrium. | Kaplan N et al. | — | 1992 | → |
| Expressed genes, Alu repeats and polymorphisms in cosmids sequenced from chromosome 4p16.3. | McCombie WR et al. | — | 1992 | → |
| Failure to replicate linkage between chromosome 5q11-q13 markers and schizophrenia in 28 families. | Campion D et al. | — | 1992 | → |
| Framework multipoint map of the long arm of human chromosome 4 and telomeric localization of the gene for FSHD. | Weiffenbach B et al. | — | 1992 | → |
| Genetics and the risk of coronary heart disease. | Harrap SB et al. | — | 1992 | → |
| Genome mapping: cDNA approaches. | Southern EM | — | 1992 | → |
| How genetically heterogeneous are the major psychiatric disorders? | Barondes SH | — | 1992 | → |
| Huntington disease in Finland: a molecular and genealogical study. | Ikonen E et al. | — | 1992 | → |
| Huntington's disease and neurotoxins. | Martin JB et al. | — | 1992 | → |
| Huntington's disease: prenatal screening for late onset disease. | Post SG | — | 1992 | → |
| Hypervariable 'minisatellite' regions in human DNA. 1985. | Jeffreys AJ et al. | — | 1992 | → |
| Initiation and execution of movement sequences in those suffering from and at-risk of developing Huntington's disease. | Bradshaw JL et al. | — | 1992 | → |
| Isolation and characterization of new highly polymorphic DNA markers from the Huntington disease region. | Weber B et al. | — | 1992 | → |
| Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex. | Beal MF et al. | — | 1992 | → |
| Linkage analysis and predicting genetic disease. | Boughman JA et al. | — | 1992 | → |
| Localization of the D5 dopamine receptor gene to human chromosome 4p15.1-p15.3, centromeric to the Huntington's disease locus. | Eubanks JH et al. | — | 1992 | → |
| Mapping of ornithine aminotransferase gene sequences to mouse chromosomes 7, X, and 3. | Ramesh V et al. | — | 1992 | → |
| Mapping quantitative trait loci for behavioral traits in the mouse. | Johnson TE et al. | — | 1992 | → |
| Molecular biology of neurological diseases. | Cumming WJ | — | 1992 | → |
| Neurofibromatosis type 2 appears to be a genetically homogeneous disease. | Narod SA et al. | — | 1992 | → |
| New insights into the clinical features, pathogenesis and molecular genetics of Huntington disease. | Kremer B et al. | — | 1992 | → |
| Nonrandom association between Huntington disease and two loci separated by about 3 Mb on 4p16.3. | Andrew S et al. | — | 1992 | → |
| One hundred requests for predictive testing for Huntington's disease. | Simpson SA et al. | — | 1992 | → |
| Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk. | Bloch M et al. | — | 1992 | → |
| Prenatal diagnosis of Huntington's disease (HD): experiences with six cases and PCR. | Thies U et al. | — | 1992 | → |
| Presymptomatic testing for huntington diseases: Recommendations for counseling. | Quaid KA | — | 1992 | → |
| Presymptomatic testing for Huntington's disease in the United Kingdom. The United Kingdom Huntington's Disease Prediction Consortium. | Tyler A et al. | — | 1992 | → |
| Presymptomatic testing for Huntington's disease in Wales 1987-90. | Tyler A et al. | — | 1992 | → |
| Radiation-reduced hybrids for the myotonic dystrophy locus. | Brook JD et al. | — | 1992 | → |
| Recombination of 4p16 DNA markers in an unusual family with Huntington disease. | Pritchard C et al. | — | 1992 | → |
| Reduced regional cerebral blood flow in Huntington's disease studied by SPECT. | Hasselbalch SG et al. | — | 1992 | → |
| Sequence-tagged sites (STSs) spanning 4p16.3 and the Huntington disease candidate region. | Gusella JF et al. | — | 1992 | → |
| Significant linkage disequilibrium between the Huntington disease gene and the loci D4S10 and D4S95 in the Dutch population. | Skraastad MI et al. | — | 1992 | → |
| Startle disease, or hyperekplexia: response to clonazepam and assignment of the gene (STHE) to chromosome 5q by linkage analysis. | Ryan SG et al. | — | 1992 | → |
| Synteny mapping in the bovine: genes from human chromosome 4. | Zhang N et al. | — | 1992 | → |
| Terminal deletion of chromosome 4p (4p16.3) shows a breakpoint between loci linked to Huntington disease. | Ikonen E et al. | — | 1992 | → |
| Testing for Huntington's disease. | Williamson R | — | 1992 | → |
| The epidemiology of Huntington's disease. | Harper PS | — | 1992 | → |
| The first decade of molecular genetics in neurology: changing clinical thought and practice. | Rowland LP | — | 1992 | → |
| The genetic analysis of human behavior: a new era? | Billings PR et al. | — | 1992 | → |
| The Huntington's disease candidate region exhibits many different haplotypes. | MacDonald ME et al. | — | 1992 | → |
| The juvenile microtubule-associated protein MAP2c is a rod-like molecule that forms antiparallel dimers. | Wille H et al. | — | 1992 | → |
| The loss of beta II-protein kinase C in the striatum from patients with Huntington's disease. | Hashimoto T et al. | — | 1992 | → |
| The NADH:ubiquinone oxidoreductase (complex I) of respiratory chains. | Walker JE | — | 1992 | → |
| The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing. | Wiggins S et al. | — | 1992 | → |
| The telomeric 60 kb of chromosome arm 4p is homologous to telomeric regions on 13p, 15p, 21p, and 22p. | Youngman S et al. | — | 1992 | → |
| Threshold model in the genetics of age-dependent disease in twins: I. General principles as applied to Alzheimer disease. | Murphy EA et al. | — | 1992 | → |
| 1990 Richardson Lecture. Challenges for neurology in the nineties: will we survive? | Martin JB | — | 1991 | → |
| A detailed multipoint map of human chromosome 4 provides evidence for linkage heterogeneity and position-specific recombination rates. | Buetow KH et al. | — | 1991 | → |
| A gene encoding a fibroblast growth factor receptor isolated from the Huntington disease gene region of human chromosome 4. | Thompson LM et al. | — | 1991 | → |
| American Society of Human Genetics presidential address, October 18, 1990. | Caskey CT | — | 1991 | → |
| Application of gene amplification by polymerase chain reaction to genetic analysis of molar mitochondrial DNA: the detection of anuclear empty ovum as the cause of complete mole. | Azuma C et al. | — | 1991 | → |
| Complex patterns of linkage disequilibrium in the Huntington disease region. | MacDonald ME et al. | — | 1991 | → |
| Covariate-dependent age-at-onset distributions for Huntington disease. | Krawczak M et al. | — | 1991 | → |
| Current perspectives on the genetics of unipolar depression. | Moldin SO et al. | — | 1991 | → |
| Defined physical limits of the Huntington disease gene candidate region. | Bates GP et al. | — | 1991 | → |
| Defining the gene: an evolving concept. | Carlson EA | — | 1991 | → |
| Differences in phenytoin biotransformation and susceptibility to congenital malformations: a review. | Van Dyke DC et al. | — | 1991 | → |
| Different gene loci for hyperkalemic and hypokalemic periodic paralysis. | Fontaine B et al. | — | 1991 | → |
| Differential diagnosis of choreiform tardive dyskinesia. | Hyde TM et al. | — | 1991 | → |
| Disease gene identification: ethical considerations. | Wexler NS | — | 1991 | → |
| DNA fingerprints of sheep using an M13 probe. | Gatei MH et al. | — | 1991 | → |
| Forensics of birds of prey by DNA fingerprinting with 32P-labeled oligonucleotide probes. | Wolfes R et al. | — | 1991 | → |
| Generation and characterization of irradiation hybrids of human chromosome 4. | Doucette-Stamm LA et al. | — | 1991 | → |
| Genetic analysis of Huntington disease in Italy. | Ajmar F et al. | — | 1991 | → |
| Genetic linkage between Huntington disease and the D4S10 locus in South African families: further evidence against non-allelic heterogeneity. | Greenberg LJ et al. | — | 1991 | → |
| Genetic linkage studies of human neurodegenerative disorders. | Tanzi RE | — | 1991 | → |
| Huntington disease-linked locus D4S111 exposed as the alpha-L-iduronidase gene. | MacDonald ME et al. | — | 1991 | → |
| Identification of multiple CpG islands and associated conserved sequences in a candidate region for the Huntington disease gene. | Weber B et al. | — | 1991 | → |
| Increased recombination adjacent to the Huntington disease-linked D4S10 marker. | Allitto BA et al. | — | 1991 | → |
| Infection of cultured striatal neurons with a defective HSV-1 vector: implications for gene therapy. | Freese A et al. | — | 1991 | → |
| Information content of the Centre d'Etude du Polymorphisme Humain (CEPH) family structures for linkage studies. | Chakravarti A | — | 1991 | → |
| Is investment in molecular genetics worthwhile? | Berrettini WH | — | 1991 | → |
| Large-scale physical mapping within the region 22q12.3-13.1 in meningioma. | Herzog R et al. | — | 1991 | → |
| Legal aspects of genetic information. | Andrews LB | — | 1991 | → |
| Linkage disequilibrium and recombination make a telomeric site for the Huntington's disease gene unlikely. | Barron L et al. | — | 1991 | → |
| Long latency EMG responses in early diagnosis of Huntington's chorea. | Leblhuber F et al. | — | 1991 | → |
| Mapping of cosmid clones in Huntington's disease region of chromosome 4. | Whaley WL et al. | — | 1991 | → |
| Myoclonus in adult Huntington's disease. | Vogel CM et al. | — | 1991 | → |
| Neurology. | Gale AN et al. | — | 1991 | → |
| Neuropsychological, neurological, and MRI correlates of dementia in advanced Huntington's disease: a single case study. | Brooker AE et al. | — | 1991 | → |
| New DNA markers in the Huntington's disease gene candidate region. | Lin CS et al. | — | 1991 | → |
| Non-random association between DNA markers and Huntington disease locus in the Italian population. | Novelletto A et al. | — | 1991 | → |
| Parental origin of chromosome 22 loss in sporadic and NF2 neuromas. | Fontaine B et al. | — | 1991 | → |
| Paternal origin of the chromosomal deletion resulting in Wolf-Hirschhorn syndrome. | Quarrell OW et al. | — | 1991 | → |
| Polymorphisms in the transcribed 3' untranslated region of eukaryotic genes. | Levitt RC | — | 1991 | → |
| Prenatal diagnosis for Huntington's disease: a molecular and psychological study. | Spurdle A et al. | — | 1991 | → |
| Presymptomatic Diagnosis of Genetic Disorders: Is it worth the anxiety? | Tannenbaum TN et al. | — | 1991 | → |
| Presymptomatic, prenatal, and exclusion testing for Huntington disease using seven closely linked DNA markers. | Skraastad MI et al. | — | 1991 | → |
| Protocol for genetic testing in Huntington disease: three years of experience in Minnesota. | Nance MA et al. | — | 1991 | → |
| Quantitative trait loci and psychopharmacology. | Plomin R et al. | — | 1991 | → |
| Quinolinic acid stimulates somatostatin gene expression in cultured rat cortical neurons. | Patel SC et al. | — | 1991 | → |
| Selective abortion and gene therapy: reflections on human limits. | Post SG | — | 1991 | → |
| Serum ferritin deficiency in Huntington's disease patients. | Bonilla E et al. | — | 1991 | → |
| Site-specific cleavage of human chromosome 4 mediated by triple-helix formation. | Strobel SA et al. | — | 1991 | → |
| Software support for Huntingtons disease research. | Conneally PM et al. | — | 1991 | → |
| The end in sight for Huntington disease? | Pritchard C et al. | — | 1991 | → |
| The genesis of the Human Genome Project. | Cook-Deegan RM | — | 1991 | → |
| The molecular genetics of schizophrenia: an overview and forward view. | McGuffin P et al. | — | 1991 | → |
| The scintigraphic evaluation of Huntington's disease and other movement disorders using single photon emission computed tomography perfusion brain scans. | Nagel JS et al. | — | 1991 | → |
| Understanding the decision to take the predictive test for Huntington disease. | Meissen GJ et al. | — | 1991 | → |
| Yeast artificial chromosome cloning of a two-megabase-size contig within chromosomal band 18q21 establishes physical linkage between BCL2 and plasminogen activator inhibitor type-2. | Silverman GA et al. | — | 1991 | → |
| 1989 Allen Award address: the American Society of Human Genetics annual meeting, Baltimore. | Botstein D | — | 1990 | → |
| Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease. | Albin RL et al. | — | 1990 | → |
| A cloned DNA segment from the telomeric region of human chromosome 4p is not detectably rearranged in Huntington disease patients. | Pritchard C et al. | — | 1990 | → |
| A genetic map of chromosome 1: comparison of different data sets and linkage programs. | Rouleau GA et al. | — | 1990 | → |
| Alzheimer's disease. Dominant susceptibility genes. | Martin GM et al. | — | 1990 | → |
| Apomorphine-induced dyskinesias after excitotoxic caudate-putamen lesions and the effects of neural transplantation in non-human primates. | Isacson O et al. | — | 1990 | → |
| A primate model of Huntington's disease: behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon. | Hantraye P et al. | — | 1990 | → |
| Association of genetic defects with yield and type traits: the weaver locus effect on yield. | Hoeschele I et al. | — | 1990 | → |
| Autosomal dominant retinitis pigmentosa: absence of the rhodopsin proline----histidine substitution (codon 23) in pedigrees from Europe. | Farrar GJ et al. | — | 1990 | → |
| A yeast artificial chromosome telomere clone spanning a possible location of the Huntington disease gene. | Bates GP et al. | — | 1990 | → |
| Construction of the physical map for three loci in chromosome band 13q14: comparison to the genetic map. | Higgins MJ et al. | — | 1990 | → |
| Current trends in the treatment of Basal Ganglia diseases. | Fahn S | — | 1990 | → |
| Defining DNA diagnostic tests appropriate or standard clinical care. | Lebo RV et al. | — | 1990 | → |
| DNA fingerprinting for forensic identification: potential effects on data interpretation of subpopulation heterogeneity and band number variability. | Cohen JE | — | 1990 | → |
| Epidemiological and linkage studies on Huntington's disease in Italy. | Frontali M et al. | — | 1990 | → |
| Equal parental origin of chromosome 22 losses in human sporadic meningioma: no evidence for genomic imprinting. | Fontaine B et al. | — | 1990 | → |
| Ethical and legal dilemmas arising during predictive testing for adult-onset disease: the experience of Huntington disease. | Huggins M et al. | — | 1990 | → |
| Ethical issues in Huntington disease presymptomatic testing. | Turner DR et al. | — | 1990 | → |
| Ethics and the new genetics. | Haan EA | — | 1990 | → |
| Exclusion testing in pregnancy for Huntington's disease. | Tyler A et al. | — | 1990 | → |
| [Freedom in research and responsibilities of scientists]. | Mittelstrass J | — | 1990 | → |
| Gene mapping and cystic fibrosis. | Barker PE | — | 1990 | → |
| Gene mapping in the idiopathic generalized epilepsies: juvenile myoclonic epilepsy, childhood absence epilepsy, epilepsy with grand mal seizures, and early childhood myoclonic epilepsy. | Delgado-Escueta AV et al. | — | 1990 | → |
| Genetic factors in Alzheimer's disease. | Nalbantoglu J et al. | — | 1990 | → |
| Genetic factors in child psychiatric disorders--I. A review of research strategies. | Rutter M et al. | — | 1990 | → |
| Genetic linkage and complex diseases, with special reference to psychiatric disorders. | Risch N | — | 1990 | → |
| Genetics and child psychiatry. | Leckman JF et al. | — | 1990 | → |
| Genetic testing for Huntington's disease. | Harper PS et al. | — | 1990 | → |
| High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. | Lichter P et al. | — | 1990 | → |
| Huntington disease in Finland: linkage disequilibrium of chromosome 4 RFLP haplotypes and exclusion of a tight linkage between the disease and D4S43 locus. | Ikonen E et al. | — | 1990 | → |
| Huntington's disease as a model for mood disorders. Clues from neuropathology and neurochemistry. | Peyser CE et al. | — | 1990 | → |
| Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals. | Penney JB et al. | — | 1990 | → |
| Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid. | Beal MF et al. | — | 1990 | → |
| Location on chromosome 15 of the gene defect causing Marfan syndrome. | Kainulainen K et al. | — | 1990 | → |
| Neural basis of behavior: animal models of human conditions. | Sanberg PR et al. | — | 1990 | → |
| On the estimation of the age at onset distribution in Huntington's chorea using the EM algorithm. | Brambilla C et al. | — | 1990 | → |
| Opinion: predictive testing for Huntington disease in childhood: challenges and implications. | Bloch M et al. | — | 1990 | → |
| Options for prenatal testing for Huntington's disease using linked DNA probes. | Brock DJ et al. | — | 1990 | → |
| Oral motor dysfunction in individuals at risk of Huntington disease. | Coleman R et al. | — | 1990 | → |
| Panic disorder: genetic considerations. | Crowe RR | — | 1990 | → |
| Physical maps of 4p16.3, the area expected to contain the Huntington disease mutation. | Bućan M et al. | — | 1990 | → |
| Search for the gene for multiple endocrine neoplasia type 2A. | Kidd KK et al. | — | 1990 | → |
| Studies on DNA markers (D4S10 and D4S43/S127) genetically linked to Huntington's disease in Japanese families. | Kanazawa I et al. | — | 1990 | → |
| "The Bar Harbor Course": a 30-year veteran in the teaching of human genetics. | Guethlein LA | — | 1990 | → |
| The human genome: a prospect for paediatrics. | Gardiner RM | — | 1990 | → |
| The human genome project--some implications of extensive "reverse genetic" medicine. | Friedmann T | — | 1990 | → |
| The molecular basis of genetic disease. | Boehm CD et al. | — | 1990 | → |
| The new genetics. | Zacharias JF | — | 1990 | → |
| The probabilistic determination of identity-by-descent sharing for pairs of relatives from pedigrees. | Amos CI et al. | — | 1990 | → |
| The quinolinic acid hypothesis in Huntington's chorea. | Bruyn RP et al. | — | 1990 | → |
| The role of inheritance in behavior. | Plomin R | — | 1990 | → |
| The triumph of linkage analysis. | Rosenberg RN | — | 1990 | → |
| Twin studies of Alzheimer's disease: an approach to etiology and prevention. | Breitner JC et al. | — | 1990 | → |
| Type II diabetes and its complications in Mexican Americans. | Stern MP et al. | — | 1990 | → |
| A biallelic RFLP of the human alpha 2-C4 adrenergic receptor gene (ADRA2RL2) localized on the short arm of chromosome 4 and encoding the putative alpha 2B receptor is identified with Bsu 36 I, using a 1.5 kb probe (p ADRA2RL2). | Hoehe MR et al. | — | 1989 | → |
| A conservative viewpoint on linkage in Alzheimer's disease. | Roses AD | — | 1989 | → |
| A controlled clinical trial of baclofen as protective therapy in early Huntington's disease. | Shoulson I et al. | — | 1989 | → |
| A DNA linkage study of Usher's syndrome excluding much of chromosome 4. | Smith RJ | — | 1989 | → |
| A genetic linkage map of 17 markers on human chromosome 21. | Warren AC et al. | — | 1989 | → |
| A genetic linkage map of the long arm of human chromosome 22. | Rouleau GA et al. | — | 1989 | → |
| A lack of genetic linkage of renin gene restriction fragment length polymorphisms with human hypertension. | Naftilan AJ et al. | — | 1989 | → |
| Alcoholism and the 'new genetics'. | Mullan M | — | 1989 | → |
| Alpha-thalassaemia in the north west of England. | Bhavnani M et al. | — | 1989 | → |
| A new approach using DNA fingerprinting for the determination of androgenesis as a cause of hydatidiform mole. | Saji F et al. | — | 1989 | → |
| A new DNA marker (D4S90) is located terminally on the short arm of chromosome 4, close to the Huntington disease gene. | Youngman S et al. | — | 1989 | → |
| Applications of molecular genetics to gastrointestinal and liver diseases. II. Clinical relevance. | Summers KM | — | 1989 | → |
| Blotting techniques for the study of DNA, RNA, and proteins. | Hayes PC et al. | — | 1989 | → |
| Clustering of multiallele DNA markers near the Huntington's disease gene. | MacDonald ME et al. | — | 1989 | → |
| Coincidental detection of Down's syndrome during prenatal testing for Huntington's disease. | Turner DR et al. | — | 1989 | → |
| Coupling of D1 dopamine receptors to the guanine nucleotide binding protein Gs is deficient in Huntington's disease. | De Keyser J et al. | — | 1989 | → |
| Decrease in a proenkephalin peptide in cerebrospinal fluid in Huntington's disease and progressive supranuclear palsy. | Iadarola MJ et al. | — | 1989 | → |
| Detection of specific DNA sequences by fluorescence amplification: a color complementation assay. | Chehab FF et al. | — | 1989 | → |
| Diagnosis of genetic disorders at the DNA level. | Antonarakis SE | — | 1989 | → |
| Different options for prenatal testing for Huntington's disease using DNA probes. | Fahy M et al. | — | 1989 | → |
| Difficulties in gene localization for Tourette's syndrome. Clinical aspects. | Kurlan R | — | 1989 | → |
| Direct analysis of single nucleotide variation in human DNA and RNA using in situ dot hybridization. | Wu DY et al. | — | 1989 | → |
| DNA analysis in juvenile Huntington disease. | Schömig-Spingler M et al. | — | 1989 | → |
| Estimation of fertility and fitness in Huntington disease in New England. | Mastromauro CA et al. | — | 1989 | → |
| Evidence from family studies that the gene causing Huntington disease is telomeric to D4S95 and D4S90. | Robbins C et al. | — | 1989 | → |
| Gene testing in autosomal dominant polycystic kidney disease: results of National Kidney Foundation workshop. Scientific Advisory Board of the National Kidney Foundation. | — | — | 1989 | → |
| Genetic linkage between Huntington's disease and D4S10 (G8) in Scottish families. | Holloway S et al. | — | 1989 | → |
| Genetic linkage mapping of chromosome 17 markers and neurofibromatosis type I. | Vance JM et al. | — | 1989 | → |
| Genetic studies of typical Alzheimer's disease. | Mohs RC et al. | — | 1989 | → |
| Homozygote for Huntington disease. | Myers RH et al. | — | 1989 | → |
| Huntington's chorea: general practitioners' knowledge about individuals' at-risk status. | Sørensen SA et al. | — | 1989 | → |
| Increase of substance P and met-enkephalin in a severely atrophied striatum without clinical expression of chorea. | Schiffmann SN et al. | — | 1989 | → |
| Inherited diseases in North American Mennonites: focus on Old Colony (Chortitza) Mennonites. | Jaworski MA et al. | — | 1989 | → |
| Inherited mental disorders. | Wahlström J | — | 1989 | → |
| Isolation and field-inversion gel electrophoresis analysis of DNA markers located close to the Huntington disease gene. | Pritchard CA et al. | — | 1989 | → |
| Isolation of a novel mildly repetitive DNA sequence that is predominantly located at the terminus of the short arm of chromosome 4 near the Huntington disease gene. | Altherr MR et al. | — | 1989 | → |
| Lack of GTP-insensitive D2 dopamine receptors in Huntington's disease. | De Keyser J et al. | — | 1989 | → |
| Linkage analysis approach to hereditary movement disorders. | Kurlan R et al. | — | 1989 | → |
| Linkage disequilibrium in Huntington's disease: an improved localisation for the gene. | Snell RG et al. | — | 1989 | → |
| Linkage to the Huntington's disease locus in a family with unusual clinical and pathological features. | Zweig RM et al. | — | 1989 | → |
| Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. | Buetow KH et al. | — | 1989 | → |
| Mapping of recombinants near the Huntington disease locus by using G8 (D4S10) and newly isolated markers in the D4S10 region. | Skraastad MI et al. | — | 1989 | → |
| Molecular genetics in the National Health Service in Britain. | Harris R et al. | — | 1989 | → |
| Molecular probes for general testicular and specific spermatogenic function. | Krawetz SA et al. | — | 1989 | → |
| Monoamine oxidase deficiency in males with an X chromosome deletion. | Sims KB et al. | — | 1989 | → |
| Mortality rate of Huntington disease in Japan: secular trends, marital status, and geographical variations. | Imaizumi Y | — | 1989 | → |
| New mutation to Huntington's disease. | Wolff G et al. | — | 1989 | → |
| Non-random association between alleles detected at D4S95 and D4S98 and the Huntington's disease gene. | Theilmann J et al. | — | 1989 | → |
| Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates. | Bloch M et al. | — | 1989 | → |
| Predictive testing for Huntington's disease. | Harper PS et al. | — | 1989 | → |
| Predictive testing for Huntington's disease with linked DNA markers. | Brock DJ et al. | — | 1989 | → |
| Prenatal exclusion testing for Huntington disease using the polymerase chain reaction. | McIntosh I et al. | — | 1989 | → |
| Presymptomatic DNA testing for Huntington's disease. | Brandt J et al. | — | 1989 | → |
| Presymptomatic testing for Huntington's disease. A case complicated by recombination within the D4S10 locus. | Curtis A et al. | — | 1989 | → |
| Principles of DNA cloning. | Miles JS et al. | — | 1989 | → |
| Psychiatry, molecular genetics and ethics: the new discoveries and the new issues. | McGrath J | — | 1989 | → |
| Recombination events suggest potential sites for the Huntington's disease gene. | MacDonald ME et al. | — | 1989 | → |
| Restriction fragment length polymorphism of the L-myc gene and susceptibility to metastasis in renal cancer patients. | Kakehi Y et al. | — | 1989 | → |
| Restriction fragment length polymorphisms for growth hormone, prolactin, osteonectin, alpha crystallin, gamma crystallin, fibronectin and 21-steroid hydroxylase in cattle. | Theilmann JL et al. | — | 1989 | → |
| Restriction fragment length polymorphisms of X chromosome among Japanese population. | Ueyama H et al. | — | 1989 | → |
| Restriction fragment length polymorphisms on the q24-q28 region of X chromosome among Japanese population. | Taga T et al. | — | 1989 | → |
| Role of molecular biology in hypertension research. State of the Art lecture. | Dzau VJ et al. | — | 1989 | → |
| Segregation of the Huntington disease region of human chromosome 4 in a somatic cell hybrid. | Cox DR et al. | — | 1989 | → |
| Social system responses to Huntington disease. | Kessler S et al. | — | 1989 | → |
| Strategies for linkage studies in schizophrenia. | Mellon CD et al. | — | 1989 | → |
| Synteny on mouse chromosome 5 of homologs for human DNA loci linked to the Huntington disease gene. | Cheng SV et al. | — | 1989 | → |
| The Huntington disease locus is most likely within 325 kilobases of the chromosome 4p telomere. | Doggett NA et al. | — | 1989 | → |
| The impact of molecular genetics on our understanding of the psychoses. | Mullan MJ et al. | — | 1989 | → |
| The motivation of at-risk individuals and their partners in deciding for or against predictive testing for Huntington's disease. | Evers-Kiebooms G et al. | — | 1989 | → |
| The paradigm of Huntington disease. | Jenkins JB et al. | — | 1989 | → |
| The prevalence and patterns of care of Huntington's chorea in Grampian. | Simpson SA et al. | — | 1989 | → |
| The quinolinic acid model of Huntington's disease: locomotor abnormalities. | Sanberg PR et al. | — | 1989 | → |
| The role of beneficence in clinical genetics: non-directive counseling reconsidered. | Yarborough M et al. | — | 1989 | → |
| The role of mitochondrial DNA in Huntington's disease. | Irwin CC et al. | — | 1989 | → |
| The use of DNA probes in preimplantation and prenatal diagnosis. | West JD | — | 1989 | → |
| Uptake of presymptomatic predictive testing for Huntington's disease. | Craufurd D et al. | — | 1989 | → |
| Using survival methods to estimate age-at-onset distributions for genetic diseases with an application to Huntington disease. | Cupples LA et al. | — | 1989 | → |
| Genomic imprinting: a possible mechanism for the parental origin effect in Huntington's chorea. | Reik W | — | 1988 | → |
| The map of chromosome 20. | Simpson NE | — | 1988 | → |